Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2021

Evaluating the Clinical Utility of a Novel Electroencephalography
System for Assessing Perioperative Neurocognition in Older
Surgical Patients
Lloyd H. Barnwell III
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Anesthesiology Commons, and the Other Nursing Commons
© L. Harold Barnwell, III, PhD, DNAP, CRNA

Downloaded from
https://scholarscompass.vcu.edu/etd/6817

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

©

L. Harold Barnwell, III
All Rights Reserved

2021

Evaluating the Clinical Utility of a Novel Electroencephalography System
for Assessing Perioperative Neurocognition in Older Surgical Patients

A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.

by

L. Harold Barnwell, III
Doctor of Nurse Anesthesia Practice (DNAP) – Virginia Commonwealth University – 2015
Master of Science in Nurse Anesthesia (MSNA) – Virginia Commonwealth University – 2014
Bachelor of Science in Nursing – Liberty University – 2009

Dissertation Chair: Thomas Corey Davis, PhD, CRNA
Associate Professor, Assistant Program Director
Department of Nurse Anesthesia, College of Health Professions

Virginia Commonwealth University
Richmond, Virginia
November, 2021

iii
Acknowledgements
“If I have seen further, it is by standing on the shoulders of giants.” – Isaac Newton
I am deeply grateful for the inspiration, guidance, and support of so many throughout this
dissertation journey. To my loving and supportive wife, Ashley, thank you for your tremendous
sacrifice that enabled this journey to be possible. Teagan, Tate Rose, and Taryn, thank you for
your bright smiles, big hugs, and persistent “kick bottom daddy” words of encouragement. Mike
Fallacaro, thank you for encouraging me to begin this journey and for your incredible ability to
inspire others to accomplish more than they ever dreamed possible. Chuck Biddle, thank you for
challenging my thoughts, encouraging my exploration, and consistently exemplifying a high
personal standard (with balance). I am grateful to my committee for their support and guidance:
Dr. Corey Davis, PhD, CRNA (Chair); Dr. Chuck Biddle, PhD, CRNA; Dr. Tyler Corson, PhD;
Dr. Ernie Steidle, PhD; Dr. Shilen Thakrar, MD; Dr. Patricia Slattum, PhD, PharmD; and Dr.
William Broaddus, MD, PhD. I would also like to thank my colleagues in the VCU Department
of Nurse Anesthesia and VCU Health System for your words of encouragement and continuous
support. Additionally, I would like to thank everyone in the VCU PhD in Health Related
Sciences program (including the GOAT cohort!) for sharing your knowledge and time with me.
Thank you to the American Association of Nurse Anesthetists (AANA) Foundation and to Nurse
Anesthesiology Faculty Associates (NAFA) for your generosity in funding the Perioperative
Brain Health project.

iv
Table of Contents
List of Tables..................................................................................................................................ix
List of Figures..................................................................................................................................x
Abstract..........................................................................................................................................xii
Chapter 1: Introduction....................................................................................................................1
Study and Chapter Overview...............................................................................................1
Background..........................................................................................................................2
Research Problem................................................................................................................3
Gap in the Literature............................................................................................................4
Theoretical Framework........................................................................................................5
Purpose Statement................................................................................................................6
Research Method.................................................................................................................6
Data Source..........................................................................................................................7
Research Question, Specific Aims, and Hypotheses...........................................................8
Study Significance...............................................................................................................9
Summary of Key Points.....................................................................................................10
Delimitations......................................................................................................................11
Assumptions.......................................................................................................................12
Definition of Terms............................................................................................................12
Organization of Remaining Chapters.................................................................................14
Chapter 2: Literature Review.........................................................................................................15
Chapter Overview…..........................................................................................................15
Anesthetics and The Brain….............................................................................................15

v
Historical Background…...................................................................................................16
Heterogeneity of Prior Studies….......................................................................................24
Postoperative Delirium (POD)...........................................................................................26
Incidence…........................................................................................................................28
Sequelae Associated with Postoperative Delirium (POD).................................................29
Risk Factors…...................................................................................................................30
Mitigation Strategies…......................................................................................................32
Pathophysiology….............................................................................................................35
Electroencephalography….................................................................................................38
Novel Point-of-Care EEG Assessment System.................................................................42
P300 Waveforms…............................................................................................................54
P300 Changes Associated with Altered Neurocognitive States…....................................56
Montreal Cognitive Assessment (MoCA)….....................................................................57
Mini-Cog©….....................................................................................................................59
Confusion Assessment Method (CAM).............................................................................60
Chapter Summary…..........................................................................................................61
Chapter 3: Theoretical Framework…............................................................................................64
Chapter Overview…..........................................................................................................64
Introduction…....................................................................................................................64
Descriptive & Explanatory…............................................................................................66
Accurate….........................................................................................................................66
Practical…..........................................................................................................................66
Simple…............................................................................................................................69

vi
Consistent….......................................................................................................................70
Acute…..............................................................................................................................70
Application of Donabedian’s Quality of Care Model........................................................71
Specific Aims & Hypotheses.............................................................................................72
Chapter Summary..............................................................................................................73
Chapter 4: Methodology…............................................................................................................74
Chapter Overview…..........................................................................................................74
Research Design…............................................................................................................74
Aims & Hypotheses...........................................................................................................75
Data Source........................................................................................................................75
Target & Accessible Populations.......................................................................................78
Sampling Strategy..............................................................................................................79
Eligibility Criteria..............................................................................................................80
Power Analysis..................................................................................................................81
Data Management..............................................................................................................82
Variables & Measures........................................................................................................83
Protection of Human Participants......................................................................................85
Data Cleaning.....................................................................................................................85
Descriptive Statistics..........................................................................................................86
Multivariate Statistics........................................................................................................86
Assumptions & Limitations...............................................................................................89
Chapter Summary..............................................................................................................90
Chapter 5: Results..........................................................................................................................92

vii
Chapter Overview..............................................................................................................92
Review of Data Acquisition...............................................................................................93
Data Preparation and Cleaning..........................................................................................94
Descriptive Statistical Analysis.........................................................................................95
Assumption Testing...........................................................................................................99
Statistical Analysis...........................................................................................................109
Post Hoc Power Analysis.................................................................................................113
Chapter Summary............................................................................................................114
Chapter 6: Conclusions and Recommendations..........................................................................116
Chapter Overview............................................................................................................116
The Problem.....................................................................................................................116
Study Purpose, Research Questions, and Hypotheses.....................................................117
Review of Theory............................................................................................................118
Review of the Methodology.............................................................................................118
Synopsis of Major Findings.............................................................................................120
Findings Related to the Literature....................................................................................121
Limitations.......................................................................................................................123
Conclusions and Recommendations for Future Research...............................................126
References....................................................................................................................................130
Vita...............................................................................................................................................162
Appendix A..................................................................................................................................163
Appendix B..................................................................................................................................164
Appendix C..................................................................................................................................166

viii
Appendix D..................................................................................................................................167
Appendix E..................................................................................................................................204
Appendix F..................................................................................................................................255

ix

List of Tables
1. Reported Incidence of Cognitive Changes Following a Variety of Surgical Procedures.......20
2. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Delirium Criteria….........27
3. Postoperative Sequelae Associated with Postoperative Delirium (POD)...............................31
4. Risk Factors for the Development of Postoperative Delirium (POD)………........................31
5. A Summary of Etiological Hypotheses for Delirium.............................................................36
6. WAVi MedicalTM System Components..................................................................................43
7. Study Purpose, Aims, and Hypotheses...................................................................................76
8. Eligibility Criteria and Rationale............................................................................................80
9. Variables, Measurements, and Data Classification.................................................................84
10. Study Variables and Coding...................................................................................................94
11. Descriptive Statistics – Aim 1.................................................................................................96
12. Descriptive Statistics – Aim 2.................................................................................................98

x

List of Figures
1. The WAVi MedicalTM Neurocognitive Assessment Platform..................................................7
2. Standardized Nomenclature of Perioperative Neurocognitive Disorders...............................25
3. A Visual Summary Differentiating Hyperactive Versus Hypoactive Delirium.....................28
4. Hypothetical Perioperative Cognitive Trajectory...................................................................39
5. EEG Headset: WAVi MedicalTM System (Boulder, CO).......................................................45
6. Standard 10-20 EEG Montage................................................................................................45
7. WAVi MedicalTM System (Boulder, CO) eSocs....................................................................46
8. WAVi MedicalTM eSoc Inside the Metallic Ring of a Headset Receptacle............................46
9. Online Competency-based Training Module..........................................................................47
10. Desktop Application Electrode Contact Assessment Page--Good Contact............................50
11. Desktop Application Electrode Contact Assessment Page--Poor Contact.............................50
12. Subject Participating in Neurocognitive Assessment.............................................................51
13. One-minute Baseline Eyes Closed Raw-wave EEG Assessment...........................................52
14. Four-minute Eyes Closed P300 Assessment...........................................................................54
15. Illustrated Event Related Response Test, Baseline Waveform, & P300 Waveform...............55
16. Average P300 Waveform Captured at a Single Site (Pz).......................................................55
17. Average P300 Waveforms Captured at All 10-20 EEG Montage Sites.................................56
18. Donabedian’s Theoretical Model for Evaluating the Quality of Medical Care......................65
19. Patient Handoff Structures, Processes, & Outcomes Based on Donabedian’s Model............67
20. Example of Structures, Processes, & Outcomes of Surgical Care..........................................69
21. Specific Structures, Processes, & Outcomes for This Study..................................................71
22. Research Design for the Perioperative Brian Health Prospective Observational Trial...........76

xi
23. Study Exclusion Flow Chart...................................................................................................93
24. Histogram of the Distribution of the Aim One DV, MoCA Score.......................................101
25. Histogram of the Distribution of the Aim One IV, Amplitude.............................................101
26. Histogram of the Distribution of the Aim One IV, Latency.................................................102
27. SPSS Output: Skewness and Kurtosis of the Aim One Variables........................................102
28. Scatterplot of the Distribution of the Aim One IV, Amplitude and DV, MoCA Score........103
29. Scatterplot of the Distribution of the Aim One IV, Latency and DV, MoCA Score............103
30. SPSS Output: Collinearity Statistics of the Aim One Variables...........................................104
31. Histogram of the Distribution of the Aim Two DV, Amplitude Change Score...................106
32. Histogram of the Distribution of the Aim Two DV, Latency Change Score.......................106
33. Histogram of the Distribution of the Aim Two IV, PNMMA (Yes / No)............................107
34. SPSS Output: Skewness and Kurtosis of the Aim Two Variables........................................107
35. Boxplot of the Aim Two DV, Amplitude Change Score and IV, PNMMA (Yes / No).......108
36. Boxplot of the Aim Two DV, Latency Change Score and IV, PNMMA (Yes / No)...........108
37. SPSS Output: Model Summary for Analysis of H1..............................................................109
38. SPSS Output: Coefficients for Analysis of H1......................................................................110
39. SPSS Output: Model Summary for Analysis of H2..............................................................110
40. SPSS Output: Coefficients for Analysis of H2......................................................................111
41. SPSS Output: Descriptives for Analysis of H3.....................................................................112
42. SPSS Output: ANOVA for Analysis of H3...........................................................................112
43. SPSS Output: Descriptives for Analysis of H4.....................................................................113
44. SPSS Output: ANOVA for Analysis of H4...........................................................................114

Abstract
EVALUATING THE CLINICAL UTILITY OF A NOVEL ELECTROENCEPHALOGRAPHY
SYSTEM FOR ASSESSING PERIOPERATIVE NEUROCOGNITION IN OLDER
SURGICAL PATIENTS
L. Harold Barnwell, III, PhD, DNAP, CRNA
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2021
Dissertation Chair: Thomas Corey Davis, PhD, CRNA
Associate Professor, Assistant Program Director
Department of Nurse Anesthesia, College of Health Professions
Postoperative delirium (POD) is a public health and research priority (American Society
of Anesthesiologists, 2019). POD is a risk factor for long-term neurocognitive decline, and the
rate of decline is directly proportional to the severity of POD (Vasunilashorn et al., 2018).
Baseline cognitive function is a strong, independent predictor for POD (Culley et al., 2017). The
International Perioperative Neurotoxicity Working Group recommends baseline cognitive
function be assessed for older patients prior to surgery and anesthesia (Berger, et al., 2018).
Perioperative cognitive screening tools trialed in anesthesia are not routinely incorporated into
clinical practice related to validity, reliability, or practicality problems (Berger, et al., 2018). The
ideal perioperative cognitive screening tool would be rapid, easily-administrable, valid, reliable,
automatically scored, void of language, cultural, and education bias and cost-efficient (Axley &
Schenning, 2015). No such tool has been identified to date. This study, guided by Donabedian’s
theoretical model, evaluated the utility of a novel point-of-care (POC) electroencephalography

(EEG) system, WAVi MedicalTM (Boulder, CO), for the perioperative neurocognitive
assessment of older surgical patients. This study conducted a secondary analysis of data from the
“Perioperative Brain Health” – IRB HM20019839 study. The “Perioperative Brain Health” study
is an ongoing study collecting both pre- and postoperative questionnaire-based neurocognitive
assessments alongside WAVi-derived P300 auditory evoked potentials. Data was analyzed using
regression and analysis of variance. The WAVi MedicalTM system may one day offer anesthesia
providers a novel neurocognitive assessment tool for predicting, identifying, and tracking
perioperative neurocognitive disorders in older surgical patients.

Keywords: perioperative neurocognitive disorders, postoperative delirium, older surgical
patients, geriatrics, electroencephalography, EEG, auditory evoked potentials, anesthesia

Chapter 1: Introduction
Study and Chapter Overview
The purpose of this study was to explore baseline and postoperative neurocognitive
characteristics that may help to establish novel predictive and trend metrics for perioperative
neurocognitive assessment in older surgical patients. This study is important because
neurobiomarkers obtainable with a new point-of-care (POC) electroencephalography (EEG)
brain assessment device, WAVi MedicalTM (Boulder, CO), might provide anesthesia providers
with a more detailed perioperative assessment of a patient’s brain, the primary target of
anesthesia, than is currently available with questionnaire-based assessment tools (e.g., Montreal
Cognitive Assessment (MoCA), Mini-Cog©, Confusion Assessment Method (CAM)). This study
assessed the potential for P300 auditory evoked potentials (AEPs) obtained using the WAVi
MedicalTM cognitive screening system to identify and track perioperative brain health in older
surgical patients to fill a gap in the literature in the quest to discover the ideal perioperative
cognitive screening tool.
The study is significant because, long-term, such a device may assist researchers and
clinicians in determining neurobiomarkers that could be utilized to develop a perioperative brain
health protection protocol to reduce the incidence and/or severity of perioperative neurocognitive
disorders, such as postoperative delirium (POD), in older surgical patients. Patients experiencing
POD present with varying degrees of confusion and inattention. This cognitive state is associated
with diminished recovery, increased length of stay, higher rates of morbidity and mortality, and
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escalated health care costs (Saczynski et al., 2012; Koster et al., 2012; Hshieh et al.,
2017; Sprung et al., 2017; Aranake-Chrisinger & Avidan, 2017).
Chapter one offers a succinct background on POD and perioperative neurocognitive
assessment. Concise summaries of the study’s purpose and significance are provided. Brief
overviews of the study’s theoretical framework and methodology are presented. The chapter
concludes with the organization of remaining chapters.
Background
POD, a state of disorganized thinking and inattention, complicates the postoperative
recovery of a significant number of surgical patients age 60 years and older (American Geriatrics
Society, 2015). Patients suffering POD may present as sluggish or restless with impaired
cognitive function for up to one week following surgery and anesthesia (American Geriatrics
Society, 2015). A subset of patients, 12-21%, who suffer POD following non-cardiac surgery
show signs of a postoperative neurocognitive disorder that lasts up to 3 months and 10%
demonstrate reduced cognitive function one to two years later (Abildstrom et al., 2000; Evered
and Silbert, 2018). Pediatric and young adult patients may experience emergence delirium for
approximately thirty minutes following surgery and anesthesia. However, as patients advance in
age over the age of 60 years, they are more likely to experience POD and associated long term
cognitive sequelae than are pediatric or young adult patients (Sanders et al., 2011). As such, this
study focused on older adults.
Over 30 POD risk factors have been identified making preoperative prediction
challenging across a wide variety of surgical procedures. POD is problematic because it
distresses patients, loved ones, and caregivers and is associated with: 1) diminished functional
recovery, 2) prolonged length of stay, 3) increased care dependency, 4) increased long-term
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morbidity & mortality, and 5) increased health-care costs (Wu et al., 2019). For these reasons,
the American Society of Anesthesiologists’ (ASA) Perioperative Brain Health Initiative
endorses identification of patients at-risk for POD and advocates for research to discover novel
POD identification, mitigation, and prevention strategies (American Society of
Anesthesiologists, 2019).
Research Problem
Anesthesia providers perform a thorough preoperative assessment of cardiovascular and
respiratory function by conducting a detailed history and physical examination (e.g. assessing
metabolic equivalency to task (METs), auscultating the heart and lungs, and reviewing pertinent
laboratory values). However, limited assessment of anesthesia’s primary target, the brain, is
routinely performed beyond assessing orientation to person, place, time, and task (i.e., alert and
oriented times four (A&O x 4)). Crosby et al. (2011) lamented this problem:
…that we currently make no effort to identify [older patients with a vulnerable brain
state] preoperatively is an embarrassing state of affairs considering that the brain is a
principal target of general anesthetic agents, the field of anesthesiology champions
thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is
so common and costly (p. 1267).
The problem is that no easily-administrable, rapid, reliable, highly sensitive and specific
assessment of neurocognitive function currently exists to preoperatively identify patients either
with or at risk for developing a perioperative neurocognitive disorder.
A POC EEG device capable of rapidly performing easily-administrable, reliable,
sensitive, and specific neurocognitive assessments at the bedside might enable anesthesia
providers to better assess baseline neurocognitive function in older surgical patients prior to
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surgery and anesthesia. Objective assessments derived from such a device may also detect
neurocognitive changes (e.g., mild or even subsyndromal cognitive impairments) that are
currently missed in a subset of patients by clinically utilized cognitive assessment tools (e.g.,
MoCA, Mini-Cog©, and CAM) as well as track the progression of patients’ cognitive status to
determine if, and when, neurocognitive function is improving or worsening perioperatively.
Gap in the Literature
The WAVi MedicalTM system is a novel U.S. Food and Drug Administration (FDA)cleared POC EEG hardware and software system for rapidly assessing auditory evoked potentials
(AEPs) to assess cognitive function. AEPs, also known as auditory event-related response tests,
assess the brain’s response to a novel stimulus and are conducted using an oddball paradigm (van
Dinteren et al., 2014). An oddball paradigm consists of the presentation of a random assortment
of auditory stimuli (e.g., combination of high- and low-pitched tones). During AEP testing,
healthy brains process and respond to a novel stimulus (e.g., high-pitched tones) differently than
when presented with a series of background stimuli (e.g., low-pitched tones). Variation in the
brain’s response to a background versus novel auditory stimulus is identifiable in the amplitude
and latency of EEG waveforms. Brain speed and efficiency are associated with signal latency
(i.e., the delay in response, measured in milliseconds) on EEG. Brain power and cognitive
resources are associated with signal amplitude (i.e., the power of a response, measured in
microvolts).
Changes in the amplitude and latency of the P300 waveform are associated with altered
neurocognitive states (Polich, 2004; Sur & Sinha, 2009; Clayton et al. 2020). Specifically,
reduced P300 amplitude is indicative of a state of neurobiological vulnerability (Sur & Sinha,
2009). P300 event-related evoked response tests can be used as a neurophysiological marker for
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even mild neurocognitive disorders (Levada et al., 2016). Yener et al. (2013) demonstrated that
evoked potential tests can be used to detect mild cognitive impairment. Parra et al. (2012)
reported that P300 is a “very useful method for the preclinical assessment of [Alzheimer’s
disease], particularly in populations with low socioeconomic and education levels (p. 1).” AEP
testing may have utility for assessing and tracking patients’ neurocognitive function in the
perioperative setting.
The WAVi MedicalTM system is a unique device that utilizes innovative saline soaked
fabric electrodes, eSocsTM, to conduct and capture the brain’s electrical activity and an integrated
artifact detection software system that enhances test-retest and inter-rater reliability when
conducting POC EEG-based assessments. These system characteristics improve the clinical
practicality of rapidly performing EEG-based neurocognitive assessments. The WAVi
MedicalTM system was successfully used to assess baseline cognitive function and track changes
over time in individuals with traumatic brain injury (Grover et al., 2017; Clayton et al., 2020).
The WAVi MedicalTM system is currently being used as a neurocognitive assessment tool in a
National Institutes of Health (NIH)-funded chronic pain study (National Institutes of Health,
2018). The WAVi MedicalTM system is also being utilized to measure onset and progression of
cognitive decline in preclinical Alzheimer's patients at the University of Texas at Dallas
(Clinicaltrials.gov, 2018). The current study is innovative in that the WAVi MedicalTM system
has never been evaluated as a neurocognitive assessment tool for perioperative neurocognitive
disorders.
Theoretical Framework
The study implements Donabedian’s theoretical model to guide measurement of
improvement in quality of care (Donabedian, 2005). The three primary constructs used to guide
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this research were: structure (e.g., attributes of a patient, system, or provider), process (i.e.,
current best practice versus potential new intervention), and outcome (i.e., the end result of
improvement work). Structure refers to the physical and organizational characteristics where
healthcare occurs. In this study, structure references the perioperative setting (i.e., the
preoperative assessment, communication, and education clinic (PACE)), preoperative holding
area, operating room, post anesthesia care unit, and patient follow-up). Process refers to the care
provided, and outcome refers to the effect of the intervention. The process-outcome being
considered is the potential utility of P300 neurobiomarkers versus best medical practice (e.g.,
Montreal Cognitive Assessment (MoCA)) to identify and track perioperative neurocognition in
older surgical patients.
Purpose Statement
The purpose of this study was to explore baseline and postoperative neurocognitive
characteristics that may help to establish novel predictive and trend metrics for perioperative
neurocognitive assessment in older surgical patients. These neurobiomarkers might enable a
more detailed perioperative assessment of a patient’s brain state than do questionnaire-based
assessment tools. Long-term, these assessments may assist the development of a perioperative
brain health protection protocol to reduce the incidence and/or severity of perioperative
neurocognitive disorders in older surgical patients.
Research Method
To evaluate the utility of P300 AEPs for assessing and tracking perioperative brain health
in older surgical patients, the following methodology was used. The study employed a nonexperimental ex post facto secondary data analysis design to retrospectively: 1) compare
participants’ baseline P300 AEPs to MoCA scores before surgery and anesthesia and 2) evaluate
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for group differences in pre- to postoperative P300 AEP change scores between participants who
received two or more potentially neuroprotective multimodal anesthetic adjunct medications
versus those who did not.
Data was analyzed using a combination of regression and analysis of variance (ANOVA).
This study used regression to gauge whether P300 AEPs are predictive of participants’ MoCA
scores. This study used ANOVA to assess for group differences in change scores (i.e., the
change from preoperative baseline to postoperative scores) between participants who received
two or more potentially neuroprotective multimodal anesthetic agents and participants who did
not.
Data Source
Data for this study was extracted from the VCU/VCUHS research electronic data capture
(REDCap®) database: “Perioperative Brian Health” – PID 22988. Data in this database was
collected using a longitudinal, repeated measures design to conduct a prospective observational
trial with a set of pretests and multi-observation post-tests. Preoperative baseline neurocognitive
assessments were completed using the WAVi MedicalTM software and hardware system and
MoCA (see Appendix B). Figure 1 depicts the WAVi MedicalTM neurocognitive assessment
platform.
Figure 1
The WAVi MedicalTM Neurocognitive Assessment Platform

7

Following surgery and anesthesia, participants underwent postoperative neurocognitive
assessments using the WAViMedTM system, Mini-Cog©, and CAM. At the time of this study’s
analysis, the primary study’s database contained 20 participant records. The impact of this
study’s sample size on statistical conclusion validity was noted and accepted as this was a proofof-concept study.
Research Question, Specific Aims, and Hypotheses
This study’s research question was: Could P300 AEPs obtained using the WAVi
MedicalTM system potentially enhance perioperative brain health assessment and provide
neurobiomarkers that aid in the development of perioperative brain health protection protocols
for older surgical patients?
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300
amplitude (i.e., brain power) and P300 latency (i.e., brain speed) to predict participants’
cognitive function. This study used regression to understand whether auditory P300
amplitude (in microvolts) and auditory P300 latency (in milliseconds) predict cognitive
function among older surgical patients as assessed by MoCA. Each variable was
considered independently as they measure two separate constructs of neurocognition,
namely cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between
participants who received two or more potentially neuroprotective multimodal anesthetic
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adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did
not.
Hypothesis #3: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a larger positive change in their
P300 amplitude, measured as a pre- to postoperative change score in microvolts.
Hypothesis #4: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in
their P300 latency relative to their baseline, measured as a pre- to postoperative
change score in milliseconds.
Study Significance
This study was important because it demonstrated that the WAVi MedicalTM system
could be employed as a research tool for neurocognitive assessment within the perioperative
clinical setting. Pending further investigation, the WAVi MedicalTM system may one day enable
anesthesia providers to: 1) perform a rapid, valid, and reliable neurocognitive assessment that is
more sensitive and specific than questionnaire-based cognitive screening tools (e.g., MoCA,
Mini-Cog©, and CAM), 2) predict POD risk and stratify patients into risk categories, 3) detect
mild cognitive impairments currently missed by brief cognitive screening tools (e.g., MoCA,
Mini-Cog©, and CAM), and 4) objectively track the progression of postoperative cognitive
changes over time. This contribution is significant because a device capable of rapidly and
reliably predicting, identifying, and tracking perioperative neurocognitive disorders (e.g., POD)
may enable anesthesia providers to develop and evaluate the effectiveness of perioperative brain
health protection protocols, clinical pathways, and pharmacologic strategies that reduce the
incidence and severity of these disorders in older surgical patients. These processes could
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potentially improve patient outcomes and reduce care costs associated with perioperative
neurocognitive disorders (Axley & Schenning, 2015).
Summary of Key Points
Neurocognitive decline associated with surgery and anesthesia complicates the recovery
of a subset of older surgical patients (American Geriatrics Society, 2015). POD, the first acute
event of postoperative neurocognitive impairment, is a public health and research priority of the
American Society of Anesthesiologists (ASA), American College of Surgeons, American
Geriatrics Society, American Heart Association, Alzheimer’s Association, and American
Association of Retired Persons (Mahanna-Gabrielli et al., 2019). The precise mechanism causing
POD has yet to be elucidated and is likely multifactorial (Wu et al., 2019). What is known is that
baseline cognitive function is a strong, independent predictor for POD in older surgical patients
(Culley et al., 2017). POD is a risk factor for long-term neurocognitive decline, and the rate of
decline is directly proportional the severity of POD (Vasunilashorn et al., 2018).
The International Perioperative Neurotoxicity Working Group recommends that baseline
cognitive function be assessed in older surgical patients prior to surgery and anesthesia (Berger,
et al., 2018). Several cognitive screening tools have been trialed in anesthesia practice (e.g.,
MoCA, Mini-Cog©, and Mini-Mental State Exam (MMSE)) (Berger, et al., 2018). However,
none of these tools have been widely adopted into routine clinical practice related to validity,
reliability, and practicality concerns (Berger, et al., 2018). Therefore, the ASA’s Perioperative
Brain Health Initiative advocates for the identification and evaluation of novel screening tools
for predicting, identifying, and tracking POD in older surgical patients (American Society of
Anesthesiologists, 2019).
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The ideal cognitive screening tool for the preanesthetic assessment of baseline cognitive
function would be rapid, easily-administrable, valid, reliable, automatically scored, void of
language, cultural, and education bias and cost-efficient (Axley & Schenning, 2015). No such
tool has been identified to date. This study systematically evaluated the utility of a novel POC
EEG hardware and software system, WAVi MedicalTM, for perioperative neurocognitive
assessment.
The WAVi MedicalTM system employs auditory event-related response tests as a metric
of cognition. Leveda et al. (2016) reported that P300 AEPs can be used as a neurobiomarker for
even mild neurocognitive disorders. Culley et al. (2017) reported that baseline cognitive function
is a strong, independent predictor for POD in older surgical patients. The WAVi MedicalTM
system may offer anesthesia providers a rapid and reliable neurocognitive assessment tool that
could potentially be used to predict, identify, and track the progression of perioperative
neurocognitive disorders (e.g., POD) in older surgical patients.
Delimitations
The data analyzed in this study was sourced from another ongoing research project that
began data collection in 2020 and plans to continue through a date yet to be determined related to
unanticipated, unpredictable, and prolonged research restrictions due to COVID-19. The study
included only data collected within a single health system, VCU/VCUHS. VCU is an urban
research university that is ranked 32nd in the nation by the NIH for its strength in
interdisciplinary neuroscience research (Virginia Commonwealth University, 2019). VCUHS is a
level one trauma and regional referral center that performs ~25,000 surgical procedures each
year (Virginia Commonwealth University, 2019). Those evaluated in the study consisted of older
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surgical patients undergoing anesthesia for elective, non-cardiac procedures lasting longer than
one hour who met eligibility criteria.
Assumptions
The principal assumption in this study is that the WAVi MedicalTM system provides valid
and reliable assessment of P300 waveforms. This assumption was reasonable given: 1) a
multitude of previous studies utilize P300 evoked potentials as a neurocognitive assessment
metric, 2) at least two research teams have recently published data captured using the WAVi
MedicalTM system, and 3) similar ongoing neurocognitive clinical studies are employing the
WAVi MedicalTM system. Mulkey et al. (2019) accepted similar assumptions as the first
investigators to evaluate the Ceribell device (Ceribell, Inc., 2018) as a delirium identification and
assessment tool in the intensive care unit (ICU).
Definition of Terms
▪

Cognition: conscious intellectual activity (e.g., thinking, reasoning, remembering)

▪

Neurocognitive: relating to the central nervous system’s structures and processes that
enable cognitive functions

▪

Delirium: a serious, abrupt change in brain function causing confusion and altered
environmental awareness

▪

Postoperative delirium (POD): the first acute event of neurocognitive impairment
occurring up to one week postoperatively or discharge, whichever is first (Evered et al.,
2018)

▪

Predisposing risk factors: factors that make someone inclined to a condition

▪

Precipitating risk factors: factors that cause a condition
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▪

Metabolic derangement: a condition caused by an abnormal metabolic process (e.g.,
diabetes, obesity, hypertension)

▪

Delayed neurocognitive recovery: cognitive decline with symptoms diagnosed up to one
month following surgery and anesthesia (Evered et al., 2018)

▪

Postoperative neurocognitive disorder: cognitive decline with symptoms diagnosed
between one month and one year post-surgery and anesthesia (Evered et al., 2018)

▪

Electroencephalography: the measurement of electrical activity in different parts of the
brain and the recording of such activity as a visual trace

▪

Point-of-care testing: testing at the place and time patient care is being provided

▪

Auditory evoked potential: a time-locked electrical signal elicited from the brain in
response to an auditory stimulus

▪

Event-related potential: minute changes in the electrical activity of the brain produced by
a specific event or stimulus

▪

Amplitude: the maximum distance from equilibrium of a waveform at a given point in
time

▪

Latency: the delay between signal initiation and conduction

▪

Vascular event: abnormal medical condition caused by a critical vascular disease related
event blocking the delivery of oxygen to body tissues (e.g., stroke or myocardial
infarction)

▪

Preoperative: denoting the period before surgery

▪

Intraoperative: denoting the period during surgery

▪

Postoperative: denoting the period following surgery

▪

Perioperative: denoting the period before, during, and following surgery
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▪

Anesthetic depth: the degree an anesthetic medication depresses the central nervous
system

Organization of Remaining Chapters
The remainder of this study is organized into five chapters, a bibliography, and
appendices. Chapter 2 presents a comprehensive synthesis of the literature. Chapter 3 describes
the study’s guiding theory. Chapter 4 explains the study design and research methodology. The
WAVi MedicalTM system, the data source’s study protocol, and sample determination are
delineated. Data analysis and discussion of study findings are offered in chapter 5 following the
study. Chapter 6 provides a summary of key points, conclusions, and recommendations.
Bibliography and appendices follow.
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Chapter 2: Literature Review
Chapter Overview
Chapter two reviews literature related to perioperative neurocognitive disorders,
specifically risk factors, perioperative cognitive assessment, and associated postoperative
sequelae. The chapter provides a historical background for this study, defines postoperative
delirium (POD), and reviews the current state of the science of perioperative brain health. A gap
in the literature is established, and aims and hypotheses are presented.
Anesthetics and The Brain
Anesthetics are believed to exert their effects by altering the brain’s ability to make
neuronal connections (i.e., communicate from one brain cell to another) (Flood & Shafer,
2015a). Neuronal connections are the physical basis for consciousness (Pepperell, 2018). Brain
cells communicate with one another by sending neurotransmitters (i.e., chemical messenger
molecules) across the gaps that exist between cells (Flood & Shafer, 2015b). These gaps are
called as synapses or junctions. When one brain cell sends a signal to another brain cell,
neurotransmitters (e.g., acetylcholine, dopamine, norepinephrine, gamma aminobutyric acid
(GABA), glutamate, glycine, galanin, etc.) are released in response to an action potential (Flood
& Shafer, 2015b). An action potential is a change in the cell’s electrical potential caused by the
movement of ions (e.g., sodium, potassium, calcium, chloride, etc.) (Flood & Shafer, 2015b).
Anesthesia providers administer medications that alter one or more of these neuronal
communication processes (Purdon et al., 2015). Following anesthesia, these neuronal
connections may not return to patients’ baseline levels in older adults as rapidly or completely as
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they do in younger adults (Berger et al., 2018; Mahanna-Gabrielli et al., 2019; Wu et al., 2019;
Wu et al., 2019).
Anesthesia is necessary when a patient requires surgery. However, exposing the aged
brain to an anesthetic (e.g., intravenous, inhaled, or regional) may contribute to transient and/or
long-lasting neurocognitive impairment (Berger et al., 2018; Mahanna-Gabrielli et al., 2019; Wu
et al., 2019Wu et al., 2019). For this reason, perioperative neurocognitive disorders are a major
brain health related concern for older surgical patients (American Society of Anesthesiologists,
2019; Berger et al., 2018; Mahanna-Gabrielli et al., 2019).
Historical Background
On October 16, 1846 William Thomas Green Morton publicly demonstrated the use of
inhaled ether as an effective anesthetic in the Bulfinch Building, now known as the Ether Dome,
at Massachusetts General Hospital in Boston, Massachusetts (Fenster, 2002). Morton
administered ether to Edward Abbott for the surgical removal of a mass on Abbott’s neck
(Fenster, 2002). Abbott calmly awoke from surgery and his surgeon, Dr. John Collins Warren,
then Dean of Harvard Medical School, famously remarked “Gentleman, this is no humbug”
(Fenster, 2002). Since that famous day, the pain and suffering associated with surgery have been
attenuated like never before. Anesthetics remarkably and reversibly reduce a patient’s state of
consciousness to facilitate surgery. However, whether or not the brain returns to a state identical
to its presurgical, preanesthetic state in vulnerable patients (e.g. older patients) following surgery
and anesthesia has been questioned for over 130 years and increasingly critically examined for
the past decade (Savage, 1887; Berger et al., 2018; Mahanna-Gabrielli et al., 2019).
Savage, a psychiatrist, was one of the first physicians to describe an altered brain state in
patients following surgery and anesthesia in his presentation at the Annual Meeting of the British
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Medical Association in Dublin, Ireland in 1887. At this meeting he made the case that
postoperative neurocognitive disorders may not be a humbug either. Interestingly, Savage (1887)
opened his presentation by stating:
All writers and observers have noticed that it is very rarely that one cause alone is
efficient for the production of any attack of insanity, and that usually there are several
predisposing causes which may have been in operation for a long time [emphasis added],
as well as one or more exciting causes which may have been in action for much shorter
periods...[t]he most common form of mental disorder which comes in such cases is of the
type of acute delirious mania…though such mental disorder is generally of a temporary
character, it may pass into chronic weak-mindedness, or it may pass into (c) progressive
dementia which cannot be distinguished from general paralysis of the insane…any cause
producing delirium may produce a more permanent disorder of the mind [emphasis
added]. (p. 1405)
One notable case presented by Savage (1887) was of an “elderly” (age not specified) clergyman
who presented for surgery for rectal cancer. Following an uneventful ether anesthetic and
operation, the patient’s surgeon, Mr. Croft, noted:
[W]hen the patient became conscious, it was at once noticed that his mind was
affected…[h]e was restless, incoherent, repeating meaningless expressions…[h]is
memory seemed very defective…he remained in this state for a few weeks after his
return home, and then almost suddenly recovered [emphasis added]. (p. 1406)
In another case, Savage (1887) described a young mother who experienced an altered mental
state beginning several hours after the administration of a nitrous oxide-based anesthetic for
dental surgery:
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[T]he patient [was] delirious, conjunctivae insensible, urine and feces passed
involuntarily; irregular movements of all kinds were being made, and speech was
incessant…[s]he never regained her senses or recognized her friends. She was in a state
of delirious mania for three weeks, then settled into dementia, in which she
[remained]…[t]he points of this case are the acquired nervous instability, the acute
delirious mania, with its consecutive dementia [emphasis added]. (p. 1406)
Savage concluded by stating “I trust that enough evidence has been brought forward to induce
others to give their experience, and thus establish a relation or destroy a fallacy [emphasis
added]” (p. 1406). Sixty-eight years passed before Bedford (1955) formally and systematically
did so—establish a relation.
Bedford (1955) affirmed “It is well known, too, that in elderly people transitory
confusional states often follow operations under general anesthesia; but it is not so widely
appreciated that minor dementias and even permeant catastrophic mental impairment may
occasionally be the aftermath” (p. 6884). For this reason, Bedford systematically reviewed the
medical records of “…4250 patients over the age of 65 seen in the Oxford geriatric unit at
Cowley Road Hospital in the five years ending in June, 1954…1193 had undergone some
operation under general anesthesia…” (p. 6884). Bedford (1955) found that thirty-four percent
(410 / 1,193) of these older surgical patients had friends and family members who described that
“the patient “had never been the same since operation”” (p. 6884). Bedford identified evidence to
dispute this allegation in 290 / 410 patients, and then carefully evaluated the remaining 120 cases
in which there were reports such as:
"He’s never been able to write a decent letter since...[anesthesia and surgery]"
"He’s become so forgetful since ..."
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"She can’t be trusted to go out shopping since..."
"She’s lost all interest in the family since..."
"He’s never read a book through since..."
"He used to be so tidy but now he’s neglectful and sloppy in his habits [since]...”
"He can’t concentrate on anything since..."
"She’s become childish and unreliable since..."
"He’s not been able to attend to the business since..."
"He’s just not the same person since ..." (p. 6884)
Bedford’s (1955) report followed these anecdotal statements with 18 case-histories of
patients in which Bedford personally observed a patient’s change in mental state from
preoperative baseline health to extreme cases of postoperative dementia “…in which the patient
became virtually a human vegetable…” following surgery and anesthesia (p. 6884). It is
important to note that Bedford (1955) supported his rationale for only including the 18 cases that
he personally observed in his analysis by stating:
First, the patient’s testimony may be unreliable because of his dementia…[and]
[s]econdly, relations and friends tend to blame any dramatic incident, such as an
operation or accident, for the dementia which has in fact been slowly progressive
intellectual degradation, antedating to the operation or accident…hence the incident is
blamed, albeit falsely, for the dementia [emphasis added]. (p. 6884)
Another decade passed before rigorous evaluation of cognitive changes following cardiac
surgery began in the 1960s (Evered et al., 2016).
An ardent academic interest in cognitive dysfunction at that time largely occurred in
response to a series of reports implicating the cardiopulmonary bypass machine as a potential
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causative mechanism for altered neurocognition following open-heart surgery (Blachy & Starr,
1964; Egerton & Kay, 1964; Heller et al., 1970; Kornfeld et al., 1965). Shaw et al., (1987)
conducted one of the first prospective studies to evaluate perioperative cognitive function in 259
patients prior to, one week after, and six months following cardiac surgery using a battery of 10
neuropsychological tests. Following multivariate analysis of 91 potential contributory mechanisms,
only “cardiac failure before surgery and global impairment of left ventricular function” correlated
with long-term neurocognitive decline (Shaw et al., 1987). More recent evidence also demonstrates
that cardiopulmonary bypass alone does not cause neurocognitive dysfunction following openheart surgery (Soenarto et al., 2018). A significant number of older surgical patients present with
postoperative neurocognitive alterations following an array of both cardiac and non-cardiac
surgeries (Rudolph & Marcantonio, 2011). Table one lists 84 studies conducted over the last fifty
years reporting the wide-ranging, but significant incidence of cognitive changes in older surgical
patients following a variety of surgical procedures.
Table 1
Reported Incidence of Cognitive Changes Following a Variety of Surgical Procedures
Type of Surgery
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
Cardiac
General

Incidence of Postoperative Reference
Cognitive Changea
41%
19%
17%
31%
25%
24%
74%
66%
59%
31%
28%
23%
72%
18%
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Egerton & Kay, 1964
McClish et al., 1968
Kimball, 1969
Rubenstein & Thomas, 1969
Heller et al., 1970
Morgan, 1971
Kimball, 1972
Frank et al., 1972
Freyhan et al., 1971
Kornfield et al., 1974
Kornfield et al., 1978
Summers, 1979
Sadler, 1981
Millar, 1982

Table 1 Continued
Cardiac
Orthopedicb
Urologic
Orthopedic
(hip fracture)
Cardiac
Orthopedic
Urologic
Lung Transplant
All
Orthopedic
Orthopedic
Orthopedic
Vascular
Orthopedic
Cardiac
(aortic aneurysm)
Thoracic
(noncardiac)
Abdominal
Orthopedic
Orthopedic
Orthopedic
(hip fracture)
Orthopedic
Gastrointestinal
Orthopedic
Orthopedic
Orthopedic
(hip fracture)
Orthopedic
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
Orthopedic
Orthopedic
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic

68%
52%
7%
43%

Owens & Hutelmyer, 1982
Williams et al., 1985
Chung et al., 1987
Gutstafson et al., 1988

0%
28%
5%
73%
10%
53%
48%
41%
10%
9%
41%

Schindler et al., 1989
Rogers et al., 1989
Chung et al., 1989
Craven et al., 1990
Egbert et al., 1990
Gufstafson et al., 1991
Gufstafson et al., 1991
Williams-Russo et al., 1992
Marcantonio et al., 1994
Marcantonio et al., 1994
Marcantonio et al., 1994

14%

Marcantonio et al., 1994

5%
9%
18%
47%

Marcantonio et al., 1994
Marcantonio et al., 1994
Fischer & Flowerdew, 1995
Bowman, 1997

27%
17%
10%
11%
11%

Bowman, 1997
Kankeo et al., 1997
Litaker et al., 1998
Lynch et al., 1998
Edlund et al., 1999

5%
5%

Silverstein et al., 1999
Brauer et al., 2000

24%

Duppils et al., 2000

12%
20%
5%
41%

Duppils & Wikblad, 2000
Andersson et al., 2001
Andersson et al., 2001
Galanakis et al., 2001

27%

Edlund et al., 2001

15%

Galanakis et al., 2001
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Table 1 Continued
Vascular
Cataract
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
Orthopedic
Vascular
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
(hip fracture)
Orthopedic
Orthopedic
Vascular
Abdominal
Orthopedic
Spine
Orthopedic
Vascular
Abdominal
Spine
Spine
Vascular
Vascular
Vascular
Vascular
Vasular
Vascular
Vascular
All
Orthopedic
(hip fracture)
Spine
Cardiac

36%
4%
4%

Schneider et al., 2002
Milstein et al., 2002
Johansson et al., 2002

53%

Thakur et al., 2002

28%
10%
39%
14%

Zakriya et al., 2002
Linstedt et al., 2002
Böhner et al., 2003
Morrison et al., 2003

20%

Schuurmans et al., 2003

28%

Forminga et al., 2003

50%

Zakriya et al., 2004

6%

Kagansky et al., 2004

9%
15%
33%
51%
14%
4%
21%
22%
25%
14%
7-28%
23%
29%
25%
5%
15%
17%
12%
2%
71%

Jankowski et al., 2004
Kudoh et al., 2004
Benoit et al., 2005
Olin et al., 2005
Freter et al., 2005
Kawaguchi et al., 2006
Bickel et al., 2008
Kantznelson et al., 2009
Morimoto et al., 2009
Lee & Park, 2009
Ushida et al., 2009
Koebrugge et al., 2010
Sasajima et al., 2012
Kawatani et al., 2015
Visser et al., 2015
Raats et al., 2015
Raats et al., 2015
Sugimoto et al., 2015
Lin et al., 2016
Watne et al., 2016

8%
24%

Soh et al., 2017
Lei et al., 2017
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Table 1 Continued
Spine
Non-cardiac
Note: Studies are listed in chronological order.

18%
12%

Kang et al., 2020
Iamaroon et al., 2020

a: Reported incidence (%) of postoperative cognitive change is rounded to nearest whole number
b: Orthopedic refers to elective procedures (e.g., hip or knee arthroplasty) unless otherwise
specified
Postoperative cognitive changes in older surgical patients have been reported following
general anesthesia, sedation, and spinal anesthesia (Evered et al., 2011; Ilango et al., 2016; Patel
et al., 2018). Miller et al. (2018) conducted a systematic review of 28 randomized controlled
trials (RCTs) totaling 4,507 patients across a variety of surgical procedures and concluded that
current best evidence is also inconclusive as to whether or not the incidence of POD varies
between patients receiving general anesthesia with inhalational anesthetics (e.g., isoflurane,
sevoflurane, desflurane) versus intravenous anesthetics (e.g., propofol), but reported “with lowcertainty” that postoperative cognitive dysfunction may be reduced when patients receive a
propofol-based total intravenous anesthetic (p. 2).
Ehsani et al. (2020) recently reported a lower incidence of postoperative cognitive
dysfunction and delirium following spinal anesthesia (4.25%) versus general anesthesia (29.7%)
in a small cohort of 94 patients over the age of 50 years presenting for hip fracture fixation
indicating that further inquiry is still needed related to assessment techniques and potential
contributory mechanisms. One thing is for certain, a growing body of research continues to
investigate whether or not the brain returns to an identical preanesthetic state in vulnerable
patients (e.g., patients age 60 years and older) following surgery and anesthesia (Berger et al.,
2018; Mahanna-Gabrielli et al., 2019; Wu et al., 2019).
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Heterogeneity of Prior Studies
As one can observe from Table one, the reported incidence of neurocognitive changes
following surgery in a single patient population (e.g., orthopedic hip fracture repair) varies
significantly (5-71%). Reported explanations for this strikingly wide range center around the
significant heterogeneity of these studies (Bruce et al, 2007; Evered et al., 2018; Rudolph &
Marcantonio, 2011). Sample populations, assessment tools, and assessment epochs varied greatly
among the studies (Bruce et al, 2007; Evered et al., 2018; Rudolph & Marcantonio, 2011).
As an example, in the 17 studies evaluating neurocognitive changes following hip
fracture repair listed in Table one, six different assessment tools were used including: Neecham
Confusion Scale (1 study), CAM (8 studies), Diagnostic and Statistical Manual of Mental
Disorders (DSM) editions 3 and 4 (7 studies), Organic Brain Disorders assessment (4 studies),
and the Delirium Rating Scale (1 study). Eleven of these studies employed a single assessment
scale, and six incorporated two assessment scales. Sample sizes ranged from 10 to 546 study
participants. The mean age of study participants, when reported, ranged from 65-92. Varied
assessment epochs across these studies included: daily, twice daily, postoperative days 1 or 2 and
at discharge, postoperative day 5 only, and postoperative day 7 only. Similarly, in patients
presenting for cardiac surgery “…the incidence of delirium using chart review was 3%, noted
during routine clinical care was 8%, using interviews with nurses was 9%, and using daily
mental status testing and application of a validated diagnostic algorithm was 53%” (Evered et al.,
2018, p. 874).
Another major barrier to comparing data from prior postoperative cognition studies is the
varied operationalization of study terms (e.g., confusion, delirium, postoperative cognitive
dysfunction) (Evered et al., 2018). For this reason, recommendations for standardized
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nomenclature of cognitive changes following surgery and anesthesia were proposed by Evered
and colleagues in 2018 (Evered et al., 2018). These recommendations were developed using “a
modified Delphi procedure with no prespecified number of rounds comprised of three face-toface meetings followed by online editing of draft versions” by a multispecialty working group
(Evered et al., 2018, p.872). The recommendations propose a shift away from a previously used
umbrella term, postoperative cognitive dysfunction, to a well-defined time and score-grouped
classification system of perioperative neurocognitive disorders (Evered et al., 2018; MahannaGabrielli et al., 2019). Evered et al.’s (2018) recommended classification system for
perioperative neurocognitive disorders categorized according to the timing of onset of the
disorder is summarized by Figure 2.
Figure 2
Standardized Nomenclature of Perioperative Neurocognitive Disorders

Note: Image adapted from Mahanna-Gabrielli et al. (2019).
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This study incorporated neurocognitive assessments that were performed at patients’
baseline and postoperative day one to explore baseline and postoperative neurocognitive
characteristics that may help to establish novel predictive and trend metrics for perioperative
neurocognitive assessment in older surgical patients.
Postoperative Delirium (POD)
The clinical diagnosis of delirium was first standardized by the American Psychiatric
Association in their Diagnostic and Statistical Manual of Mental Disorders (DSM) 3rd edition
(Oosterhous et al., 2017). The DSM is an authoritative guide used by healthcare professionals
worldwide to diagnosis mental disorders (American Psychiatric Association, 2021). Delirium is
an acute change in global cognitive function and attention that presents with varying symptoms
and results from an organic etiology (Mulkey et al., 2018). POD is a term used to describe the
first acute event of neurocognitive impairment, that aligns with the DMS-5 criteria, occurring up
to one week following surgery and anesthesia or prior to hospital discharge, whichever occurs
first (Evered et al., 2018). Evered et al. (2018) were the first to operationalize the term POD
based on DSM-5 criteria and recommend this standardized nomenclature be used in research and
clinical practice. DSM-5 delirium criteria are listed in Table two (American Psychiatric
Association, 2013).
POD presents as an acute onset of altered executive functions. The term executive
functions refers to one’s ability to learn, think, reason, remember, problem solve, decide, and pay
attention. These cognitive processes essentially define one’s ability to organize and participate in
daily activities. A patient experiencing POD may be tired and sluggish (i.e. present with
hypoactive delirium), restless and distressed (i.e., present with hyperactive delirium), or a
combination of both for up to one week following surgery and anesthesia (American Geriatrics
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Table 2
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Delirium Criteria
A Disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention)
and awareness (reduced orientation to the environment).
B The disturbance develops over a short period of time (usually hours to a few
days), represents an acute change from baseline attention and awareness, and tends to
fluctuate in severity during the course of a day.
C An additional disturbance in cognition (e.g. memory deficit, disorientation, language,
visuospatial ability, or perception).
D The disturbances in Criteria A and C are not better explained by a pre-existing,
established or evolving neurocognitive disorder and do not occur in the context of a
severely reduced level of arousal such as coma.
E There is evidence from the history, physical examination or laboratory findings that the
disturbance is a direct physiological consequence of another medical condition, substance
intoxication or withdrawal (i.e. due to a drug of abuse or to a medication), or exposure to
a toxin, or is due to multiple etiologies.
Society, 2015). Hypoactive delirium accounts for ~50% of delirium cases, mixed hypo- and
hyperactive delirium for ~30% of cases, and hyperactive delirium for only 20% of cases (Hosker
& Ward, 2017).
Over 50% of patients who experience postoperative delirium present with signs of
delirium on postoperative day one (Iamaroon et al., 2020; Lin et al., 2016). However, the most
common presentation of delirium, the hypoactive form, is more difficult to identify in clinical
practice and for this reason often goes undiagnosed (Collins, 2010; Hosker & Ward, 2017).
Figure 3 differentiates the clinical signs and symptoms hyper- versus hypoactive delirium.
POD is believed to present with varied and fluctuating symptoms that can differ from
patient to patient as the result of increased dopamine, decreased acetylcholine, and divergent
amalgamations of other neurotransmitters (e.g., norepinephrine, glutamate, serotonin, and
GABA) among patients (Numan et al., 2017 as cited by Mulkey et al., 2019).
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Figure 3
A Visual Summary Differentiating Hyperactive Versus Hypoactive Delirium

Note: Image adapted from Hosker & Ward (2017).
Incidence
According to the American Geriatrics Society (2015), 19 million older adults in the
United States (US) present for surgery and anesthesia each year, and 4.5-9 million (~25-50%) of
these patients experience POD following surgery. The highest reported incidence of POD in a
prospective sample of older surgical patients is 71% (Watne et al., 2016). However, the reported
incidence varies greatly (2-71%) throughout the literature largely related to the significant
heterogeneity among studies as previously discussed. Table one lists examples. The challenge in
clinically identifying the hypoactive form of delirium may also have led to the relatively low
reported incidence of POD in some studies (Hosker & Ward, 2017; Olotu, 2019). Collins et al.
(2010) reported that 72% of patients who met criteria for a clinical diagnosis of delirium were
unidentified when presenting with hypoactive signs. Regardless, POD is the most prevalent
complication associated with surgery and anesthesia among older adult patients (American
Geriatrics Society, 2015; American Society of Anesthesiologists, 2019).
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Of additional concern is that a subset of patients who experience POD, 12-21%,
following non-cardiac surgery develop a postoperative neurocognitive disorder lasting up to 3
months, and 10% exhibit reduced cognitive function one to two years later (Abildstrom et al.,
2000; Evered & Silbert, 2018). POD is problematic because the condition distresses patients,
their loved ones, and care providers; it is also associated with inferior functional recovery, and
increased healthcare spending (Hernandez et al., 2017; Hshieh et al., 2017; Inouye et al., 2014;
Zywiel et al., 2015).
Sequelae Associated with Postoperative Delirium (POD)
Patients experiencing POD present with varying degrees of consciousness (e.g., hyper- or
hypoactive) and demonstrate a combination of intellectual, attention, and memory-related
impairments (Inouye et al., 2014; Munk et al., 2016). This state of disorganized thinking and
inattention not only distresses patients, family members and caregivers, but is also associated
with increased length of hospitalization, patient morbidity and mortality, and progression to
delayed or incomplete neurocognitive recovery (Jin et al., 2020; Koster et al., 2012; Saczynski et
al., 2012). Based on a prospective observational study of 566 older patients presenting for
elective surgery, Hshieh et al. (2017) concluded that POD was associated with “clinically
meaningful impairment of functional recovery” for up to 18 months postoperatively (p. 647).
Koster et al. (2012) reported that delirium following elective cardiac surgery is associated with a
seven-fold increased mortality risk, a nearly two-fold increase in the likelihood of hospital
readmission, and a reduction in patients’ quality of life in a sample of 300 patients.
POD is also associated with delayed neurocognitive recovery and may be predictive of
postoperative neurocognitive disorders (Sprung et al., 2017). Bickel et al. (2008) followed 41
patients who experienced POD following hip surgery and reported that 53.8% of these patients
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experienced cognitive impairment 38 months after surgery. Additionally, “[l]ogistic regression
analysis adjusted for age, sex, medical comorbidity and preoperative cognitive performance
revealed highly significant associations between delirium and cognitive impairment (OR = 41.2;
95% CI = 4.3-396.2), subjective memory decline (OR = 6.2; 95% CI = 1.5-25.8), and incident
need for long-term care (OR = 5.6; 95% CI = 1.6-19.7)” (Bickel et al., 2008, p. 26). Patients who
experience POD are also more likely to be diagnosed with dementia or experience long-term
cognitive decline than patients who have not experienced POD (Aranake-Chrisinger & Avidan,
2017; Saczynski et al., 2012; Sprung et al., 2017; Vasunilashorn et al., 2018). Whether POD
contributes to or is evidence of impending dementia is unclear.
Leslie et al. (2008) reported that patient care costs more than double in hospitalized
patients with delirium (Leslie et al., 2008). Inouye et al. (2014) reported that annual delirium
costs exceed $164 billion in the US and $182 billion in Europe. Zyweil et al. (2015) reviewed a
surgical database from a single urban academic medical center to investigate the impact of POD
on health care costs in 242 older patients after hip fracture surgery. POD was associated with an
average cost increase of $8,286 dollars per patient, and the total increased cost associated with
POD over the course of the two-year study was $961,131 dollars (Zyweil et al., 2015). Table
three lists postoperative sequelae associated with POD.
Risk Factors
Over 30 predisposing and precipitating risk factors for POD have been reported. They are
summarized in Table four (Mahanna-Gabrielli et al., 2019). Several risk assessment and PODprediction tools have recently been proposed for use during the preoperative anesthetic
assessment in an effort to risk-stratify older surgical patients and efficiently allocate limited
healthcare resources (Jin et al., 2020). However, the value of these screening tools is yet to be
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Table 3
Postoperative Sequelae Associated with Postoperative Delirium (POD)
Postoperative Sequelae
- Distress for patients, loved ones, and caregivers (Koster et al., 2012)
- Diminished functional recovery (Koster et al., 2012)
- Prolonged length of stay (Raats et al., 2015)
- Increased care dependency (Hshieh et al., 2017)
- Increased long-term morbidity risk (Gleason et al., 2016)
- Risk of long-term cognitive decline (Aranake-Chrisinger & Avidan, 2017)
- Increased mortality risk (Maniar et al., 2016; Raats et al., 2015)
- Increased healthcare costs (Brown et al., 2016, Maniar et al., 2016)
Table 4
Risk Factors for the Development of Postoperative Delirium (POD)

Pre-existing cognitive
impairment
Impaired vision or hearing
Severe illness
Preoperative infection
Poor functional status
Metabolic derangements
Polypharmacy
Pain

Risk Factors
Surgery-induced
inflammation
Malnutrition
Depression
Alcohol abuse
Sleep disturbances
History of delirium
Unidentified genetic factors
Longer duration of surgery
Age > 60 years

Invasiveness of surgery
Intensive care unit admission
Postoperative infection
Vascular events
Anesthetic depth
Perioperative stress
Dehydration
Urgency of Surgery

determined because they have either been developed in medical, rather than surgical, patient
populations (e.g., Iounye et al., 1993) or yet to be validated outside of a single surgical procedure
(e.g., Kalisvaart et al., 2006 and Kim et al., 2020). One tool, the Delirium Prediction Based on
Hospital Information (DELPHI), was validated in a small sample of 553 patients undergoing
trauma, vascular, or abdominal surgery at a single medical center (Kim et al., 2016). Risk factors
incorporated into the DELPHI model were: age, low physical activity, hearing impairment,
heavy alcoholism, history of prior delirium, ICU admission, emergency surgery, open surgery,
and increased preoperative C-reactive protein (Kim et al., 2016). However, the DELPHI’s
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predictive value in this small single-center study was only 70%, and the tool has yet to be
externally validated (Jin et al., 2020).
Mitigation Strategies
Delirium is reportedly preventable in up to 40% of patients (Siddiqi et al., 2016). In an
effort to prevent delirium, the American Geriatrics Society (2015) recommends that anesthesia
providers “avoid medications that induce delirium postoperatively in older adults (p. 140).”
According to the American Geriatrics Society (2015), these medications include: drugs with
anticholinergic properties (e.g., famotidine— a commonly used perioperative histamine (H2receptor) antagonist), corticosteroids (e.g., dexamethasone— a commonly used antiemetic and
anti-inflammatory), meperidine, sedative hypnotics (e.g., midazolam— a commonly used
preoperative sedative and anxiolytic), and polypharmacy (i.e. combining five or more
medications— which is a common practice as part of enhanced recovery after surgery (ERAS)
protocols). Unfortunately, all medications commonly utilized to produce general anesthesia (e.g.,
propofol, sevoflurane, desflurane, and isoflurane) have been associated with the development of
POD in older surgical patients (Kinjo et al., 2019; Sieber et al., 2018). Additionally, Patel et al.
(2018) reported that, based on the limited evidence available, regional anesthesia (i.e., the
injection of local anesthetics in proximity to a target nerve to block pain impulses from a region
of the body) versus general anesthesia does not reduce the incidence of POD in older patients
following hip fracture surgery.
Providers, however, cannot omit every anesthetic agent and technique when an older
patient requires surgery. Rather than omitting anesthetics agents, emerging research is
considering the possibility that co-administering potentially neuroprotective anesthetic adjunct
medications may preserve or perhaps even enhance patients’ neurocognitive function. Messick et
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al. (1987) defined neuroprotection as the “prevention or amelioration of neuronal damage
evidenced by abnormalities in cerebral metabolism, histopathology or neurologic function
occurring after a hypoxic or an ischemic event” (as cited in Hudetz et al., 2010, p. 131). Hudetz
et al. (2010) described the two goals of neuroprotection: 1) prevent cerebral ischemia and 2)
promote the recovery of ischemic neuronal tissue. Examples of potentially neuroprotective
anesthetic adjunct medications reported in the literature include ketamine, magnesium, and
lidocaine.
Rascón-Martínez et al. (2016) evaluated the impact of intraoperative ketamine on
postoperative neurocognitive function in a sample of 65 older patients undergoing ophthalmic
surgery. The investigators evaluated participants’ cognitive function pre- and post-operatively
using the Short Portable Mental Status Questionnaire (SPMSQ) (Rascón-Martínez et al., 2016).
Participants either received 0.3mg/kg ketamine intraoperatively or placebo (Rascón-Martínez et
al., 2016). Baseline preoperative SPMSQ scores were similar for both study groups (RascónMartínez et al., 2016). However, participants who received intraoperative ketamine demonstrated
improved SPMSQ scores relative to their baseline (Rascón-Martínez et al., 2016). The
postoperative SPMSQ scores of participants who received the placebo were essentially
unchanged from baseline (Rascón-Martínez et al., 2016). A systematic review and meta-analysis
by Hovaguimian et al. (2018) concluded that ketamine seemed to lower the risk of postoperative
cognitive dysfunction [RR 0.34, 95% CI [0.15, 0.73]], but not the risk for POD [RR 0.83, 95%
CI [0.25, 2.80]]. However, the quality of available evidence for this review was deemed to be
low to very-low (Hovaguimian et al., 2018). The authors advocated that future research is needed
to “further clarify the efficacy of ketamine on neurocognitive outcomes” (p. 1182).
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Bilotta et al. (2013) conducted a qualitative review of RCTs to identify potentially
neuroprotective perioperative pharmacological strategies. The authors identified two trials
demonstrating that intraoperative lidocaine infusions were neuroprotective, and two trials
concluding that intraoperative lidocaine infusions failed to offer neuroprotection (Bilotta et al.,
2013). The two trials that did not demonstrate a neuroprotective effect may have failed to do so
as a result of “…too short of an infusion period, an excessively high dose, or having included
diabetic patients who might be at an increased risk of neurological injury or a different
sensitivity to lidocaine” (Bilotta et al., 2013, p. 115). A more recent RCT comparing
intraoperative lidocaine infusions to normal saline placebo reported that lidocaine infusions
attenuated postoperative cognitive impairment in older patients following spine surgery (Chen et
al., 2015). Similar to ketamine, further research is needed to elucidate the potential perioperative
neuroprotective effects of lidocaine infusions.
Magnesium is also identified in the literature as a potentially neuroprotective anesthetic
adjunct medication. Bhudia et al. (2007) enrolled 350 participants in an RCT comparing
postoperative neurocognition between participants who received magnesium versus placebo
during cardiac surgery. The authors identified that the magnesium group demonstrated better
short-term postoperative cognitive function, notably in short-term memory, than the placebo
group (Bhudia et al., 2007). Mack et al. (2009) conducted a double-blind placebo-controlled trial
to evaluate the neuroprotective potential of intraoperative magnesium administration in 108 older
surgical patients (mean age of 68 years) undergoing carotid endarterectomy. The authors
reported that participants in the magnesium group demonstrated less postoperative cognitive
decline than those receiving placebo [OR 0.09, 95% CI 0.02-0.5, p<0.01] (Mack et al., 2009).
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While available evidence is limited in both number and quality, the potential
neuroprotective effects of ketamine, lidocaine, and magnesium warrant further inquiry. Of
particular interest, and yet to be evaluated in the setting of postoperative delirium in older
surgical patients, is the possible synergistic effect of potentially neuroprotective anesthetic
adjunct medications. Mendonca et al. (2020) reported a positive synergistic effect using a
combination of lidocaine and magnesium for perioperative pain management. Fang et al. (2020)
reported that combining lidocaine with ketamine “may be beneficial in shortening the onset of
anesthesia, promoting postoperative awaking…and [reducing the] incidence of adverse
reactions” compared to administering ketamine alone (p. 1). These findings were based on a
case-control study of 586 pediatric patients (Fang et al., 2020). It is possible that similar
synergistic effects exist related to neuroprotection in older surgical patients.
Potential benefits of varied pharmacological treatment strategies are challenging to
ascertain when 1) the etiology of POD is not fully understood and 2) clinically utilized
questionnaire-based neurocognitive assessment tools (e.g., MoCA, Mini-Cog©, and CAM))
provide a simple estimate of gross neurocognitive function, and 3) the accuracy and utility of
questionnaire-based neurocognitive assessments are questionable in certain subpopulations, such
as African American patients as well as patients with low socioeconomic and education levels.
This study evaluated for mean group differences in potential EEG-based postoperative
neurocognitive biomarkers (i.e., P300 amplitude and latency) between participants who received
two or more potentially neuroprotective anesthetic adjunct medications and those who did not.
Pathophysiology
The pathophysiology of delirium is not fully elucidated. Available evidence is largely
derived from animal models as human studies are limited (Jin et al., 2020). Prominent etiological
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hypotheses include: 1) the neurotransmitter hypothesis, 2) the stress response hypothesis, 3) the
neuroinflammation hypothesis, 4) the Alzheimer acceleration hypothesis, and 5) the cerebral
vascular hypothesis, 6) metabolic derangements, 7) electrolyte imbalances, 8) and genetic factors
(Inouye et al., 2014; Mahanna-Gabrielli et al., 2019; Jin et al., 2020). These hypotheses more
likely complement rather than compete with one another as the etiology of delirium is likely
multifactorial (Inouye et al., 2014; Mahanna-Gabrielli et al., 2019; Jin et al., 2020). Table five
summarizes these hypotheses.
Table 5
A Summary of Etiological Hypotheses for Delirium
Hypothesis
1. Neurotransmitter
Hypothesis
2. Stress Response
Hypothesis

3. Neuroinflammation
Hypothesis

4. Alzheimer’s
Acceleration
Hypothesis
5. Cerebral Vascular
Hypothesis
6. Oxygen Deprivation
Hypothesis

7. Cellular Signaling
Hypothesis

Brief Description
Altered levels of circulating neurotransmitters (e.g.,
acetylcholine and dopamine) contribute to delirium.
Perioperative stress impairs the hypothalamic-pituitary-adrenal
axis, stimulates the release of cortisol, and alters physiologic
concentrations of both inflammatory mediators (e.g., cytokines)
and neurotransmitters that contribute to delirium.
The neuroinflammatory response associated with surgery and
anesthesia triggers the release of pro-inflammatory mediators
(e.g., interleukins, prostaglandins, C-reactive protein, and tumor
necrosis factor) that may interrupt the blood-brain barrier’s
integrity and contribute to delirium.
Surgical patients may present for surgery and anesthesia with
previously undiagnosed or subclinical Alzheimer’s disease that
is identified postoperatively.
Preexisting subclinical cerebral vascular disease/events may
predispose a subset of patients to delirium.
A reduction in cerebral oxidative metabolism (i.e., the
physiologic process by which oxygen is used to produce the
energy substrate adenosine triphosphate from carbohydrates)
contributes to delirium.
Alterations in intraneuronal signal transduction mechanisms
contribute to delirium.

The predominant hypothesis discussed throughout the literature is the neurotransmitter
hypothesis. This is likely because several other hypotheses ultimately result in alterations in the
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synthesis, storage, and/or release of neurotransmitters (Mulkey et al., 2019). Nine different
neurotransmitters are purported to contribute to delirium including: acetylcholine, dopamine,
GABA, melatonin, tryptophan, serotonin, glutamate, norepinephrine, and epinephrine (Inouye et
al., 2014). However, the vast majority of experimental and observational evidence focuses on the
role that acetylcholine and dopamine play in the pathophysiology of delirium (Inouye et al.,
2014). This focus is likely related to the clinical use of anticholinergic and dopaminergic
medications in the perioperative and intensive care settings where delirium is often identified
(Inouye et al., 2014).
Acetylcholine, a combination of acetic acid and choline, is a neurochemical messenger
responsible for a wide variety of cell-to-cell communications throughout the body (Sam &
Bordoni, 2020). In the brain, acetylcholine promotes arousal, motivation, attention, and memory
(Sam & Bordoni, 2020). For this reason, researchers are working to identify specific neurologic
circuits through which acetylcholine carries out these functions as potential treatment targets for
altered neurocognitive states (Venkatesan et al., 2020). Simply stated, a decrease in acetylcholine
concentrations in the brain and central nervous system is thought to be a primary contributory
mechanism of delirium (Plaschke et al., 2007). For this reason, the American Geriatrics Society
(2015) recommends avoiding anticholinergic medications (e.g., scopolamine and amitriptyline),
when possible, in older surgical patients.
Dopamine, the precursor to norepinephrine in the catecholamine synthesis pathway, is
another neurochemical messenger involved with an array of physiologic functions. In the brain,
dopamine plays a key role in facilitating cognition and behavior. Dopamine levels can impact
mood, attention, memory, learning, motor function, and hormone release. Increased levels of
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dopamine in the brain are thought to play a major contributory role in states of hyperactive
delirium (i.e., agitation, combativeness, and hallucinations / delusions) (Mulkey et al., 2018).
Electroencephalography
Electroencephalography (EEG) changes, specifically frequency-band power ratios (e.g.,
theta/alpha ratio), associated with altered neurotransmitter concentrations are reportedly some of
the most dependable delirium biomarkers (Maldonado, 2008). EEG is also useful in
differentiating delirium caused by an organic etiology versus a functional or psychiatric disorder
(Inouye et al., 2014). Provider administered questionnaire-based neurocognitive assessments
(e.g., MoCA, Mini-Cog©, and CAM) do not differentiate this level of detail related to the causal
etiology of altered neurocognitive states. EEG-based assessment of cognitive function and the
ability to differentiate patients according to their baseline neurocognitive state may aid to
identify and stratify older surgical patients based on their risk for developing POD, inform
anesthesia care plans, and develop perioperative brain health protocols to mitigate postoperative
neurocognitive disorders.
In 1890, Adolf Beck reported the use of electrodes to note changes in the brain’s
electrical activity in response to a stimulus (Coenen & Zayachkivska, 2013). In 1924, Hans
Berger captured and graphed these changes to produce an EEG (Gibbs, F., A., Gibbs, & Lennox,
1937). In 1937, Gibbs et al. reported that anesthetic medications caused predictable and
consistent changes in the amplitude and frequency of the EEG waveform. As the science evolved
and demonstrated correlation between EEG changes and a patient’s state of consciousness, the
concept of EEG-guided anesthesia emerged (Martin, Faulconer, & Bickford, 1959). However,
EEG-guided anesthesia has not become routine because few anesthesia providers are trained in
the complex skill of raw EEG analysis and interpretation (Purdon et al., 2015).
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As technology advances and becomes more user-friendly, new POC EEG assessment
modalities may offer clinicians the ability to rapidly perform and interpret EEG-based
neurocognitive assessments. The ability to do so could be important in advancing the state of the
science of POD since some have argued, hypothetically, that postoperative neurocognitive
decline is a post hoc, ergo propter hoc (i.e., after this, therefore because of this) misattribution
fallacy (Avidan & Evers, 2016). That is to say that some researchers believe that postoperative
neurocognitive decline is the identification of preexisting, undiagnosed decline in a patient’s
neurocognitive trajectory (Avidan & Evers, 2016). Figure 4 illustrates Avidan and Evers’ (2016)
hypothetical perioperative neurocognitive trajectory model.
Figure 4
Hypothetical Perioperative Cognitive Trajectory

Note: Image adapted from Avidan and Evers, 2016.
Preexisting, undiagnosed or subclinical cognitive impairment has been identified in a
significant number of surgical patients when a battery of neuropsychological tests are employed
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(Silbert et al., 2015). Evered et al. (2011) identified that 20% of 152 patients over the age of 60
years presenting for hip replacement surgery demonstrated significant preexisting cognitive
impairment defined as a score two standard deviations below the norm on at least two of seven
neuropsychological assessments. Silbert et al. (2015) conducted a prospective observational trial
of 300 patients presenting for hip replacement surgery and 51 nonsurgical patients age 60 years
or greater and identified preexisting cognitive impairment in 32% of patients when assessed
using a battery of eight neuropsychological assessments including the: Consortium to Establish a
Registry in Alzheimer Disease (CERAD) test, Auditory Verbal Learning Test, Trail Making Test
Parts A and B, Digit Symbol Substitution Test, Controlled Oral Word Association Test, CERAD
Semantic Fluency Test , and Grooved Pegboard Test. Scott et al. (2018) reported that 51.7% of
437 patients presented for left heart catheterization with preexisting neurocognitive impairment
using a battery of both written and computerized assessments including the: CERAD Auditory
Verbal Learning Test, Trail Making Test Parts A and B, Digit Symbol Substitution Test,
Controlled Oral Word Association Test, CERAD Semantic Fluency test, and Grooved Pegboard
test.
Assessing EEG biomarkers alone or in combination with questionnaire-based cognitive
assessments may improve both the clinical detection of preexisting cognitive impairment as well
as the prediction and detection of postoperative neurocognitive alterations (Mulkey et al., 2018).
Tanabe et al. (2020) reported a significant correlation between high alpha power and increased
alpha band connectivity on preoperative EEG and the subsequent development of postoperative
delirium. Additionally, Ha et al. (2020) reported what they believe to be an EEG complexity
measure that predicts postoperative attention deficits. While useful in clinical research,
traditional EEG-monitoring modalities are not practical in the routine preoperative anesthetic
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assessment of older surgical patients related to cost, time, and technical skill limitations (Inouye
et al., 2014; Mulkey et al., 2018; Mulkey et al., 2019).
Delirium detection, especially early detection, is critical because prolonged duration of
delirium is associated with increased treatment difficulty (Mulkey et al., 2019). EEG-based
delirium assessments can often identify a delirious brain state prior to the presentation of clinical
signs and symptoms (Mulkey et al., 2019). Mulkey et al. (2019) is evaluating the clinical utility
of a novel limited lead EEG device, Ceribell, for detecting delirium in ICU patients due the
limited clinical utility of gold-standard delirium assessment tools used in research (e.g., CAM).
When CAM-ICU is incorporated into routine clinical practice, less than 50% of ICU patients
with delirium are diagnosed (Soja et al., 2008). This may be due to the extensive and recurrent
training required to maintain high inter-rater reliability and the significant staff turnover reported
among ICU nurses (Milkey et al., 2019). Similar training and staff turnover challenges would
likely be present in post-surgical units attempting to incorporate CAM for the routine assessment
of postoperative delirium. For these reasons, Inouye et al. (2014) advocate for further
investigation into the clinical use of novel EEG devices (e.g., quantitative and spectral EEG) as
they may have clinical utility, but “their performance characteristics need further investigation”
(p. 917).
Preoperative anesthesia assessments include a detailed review of cardiovascular and
respiratory function (e.g. assessing metabolic equivalency to task (METs), auscultating the heart
and lungs, and reviewing pertinent laboratory values). However, minimal assessment of
anesthesia’s primary target, the brain, is routinely completed. As previously noted, Crosby et al.
(2011) stressed this concern:
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…that we currently make no effort to identify [older patients with a vulnerable brain
state] preoperatively is an embarrassing state of affairs considering that the brain is a
principal target of general anesthetic agents, the field of anesthesiology champions
thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is
so common and costly (p. 1267).
One major barrier to completing a more thorough preoperative neurocognitive assessment is that
no rapid, easily-administrable, valid, reliable, automatically scored, and cost-efficient assessment
of neurocognitive function that is void of language, cultural, and education bias is currently
available to anesthesia providers for routine clinical use.
EEG-based P300 AEPs as neurobiomarkers might enable anesthesia providers to better
assess baseline neurocognitive function in older surgical patients prior to surgery and anesthesia
if the device and process used to conduct these assessments is practical in regards to the skills
and equipment required to perform the test and interpret the results. Objective assessments, such
as P300 AEPs, may detect mild or even subsyndromal cognitive impairments that are currently
missed in a subset of patients by clinically utilized cognitive assessment tools (e.g., MoCA,
Mini-Cog©, and CAM) as well as perioperatively track the progression of patients’ cognitive
status relative to their baseline to determine if, and when, postoperative neurocognitive
alterations occur.
Novel Point-of-Care EEG Assessment System
The WAVi MedicalTM system (Boulder, CO) is a patented, novel, noninvasive, FDAcleared POC EEG hardware and software application platform designed to rapidly perform EEGbased neurocognitive assessments (WAVi, 2019). See Appendices D, E, and F. The WAVi
MedicalTM system is a unique device that utilizes innovative saline moistened fabric electrodes,
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eSocsTM, to transmit and record the brain’s electrical activity and an integrated artifact detection
software system that enhances test-retest and inter-rater reliability when conducting POC EEGbased assessments. The WAVi MedicalTM system has been successfully used to assess baseline
cognitive function and track changes over time in individuals following traumatic brain injury
(Grover et al., 2017; Clayton et al., 2020). The system is currently being used as a
neurocognitive assessment tool in a National Institutes of Health (NIH)-funded chronic pain
study (National Institutes of Health, 2018). The system is also being utilized to measure onset
and progression of cognitive decline in preclinical Alzheimer's patients at the University of
Texas at Dallas (Clinicaltrials.gov, 2018). There is a gap in the anesthesia literature in that the
potential clinical utility of the WAVi MedicalTM system as a neurocognitive assessment tool has
never been evaluated in the perioperative setting.
The WAVi MedicalTM system consists of the following major components: headsets,
solutions, electronics, accessories, and documentation systems. Table six presents a detailed list
of the WAVi MedicalTM system components. Three headset sizes (e.g., small, medium, and
large) are included with the WAVi MedicalTM system to accommodate a wide range of head
circumferences (WAVi, 2019). The headset is made of a soft double layered closed-cell resinbased foam that easily flexes to the contour of an individual’s head (Oakley, 2018). Figure 5
shows the WAVi MedicalTM EEG Headset. Receptacles are located throughout the headset and
positioned in the locations of a standard 10-20 EEG montage. The standard 10-20 EEG montage
is depicted in Figure 6. An electrical conduction strip is located within the headset between the
two layers of foam. Unique to the WAVi MedicalTM system, single-use eSocs (i.e., ~ 1in long x
0.25in diameter plastic, fabric-covered electrodes) moistened with a 0.9% sodium chloride
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solution (i.e., normal saline) are inserted into the receptacles just prior to performing an
assessment. Figure 7 depicts an image of eSocs.
Table 6
WAVi MedicalTM System Components

-

Headsets
Small headset
Medium headset
Large headset

-

Accessories
Portable bag
Headset racks
TM
eSocs
TM
Extended eSocs
eSocTM trays
Sizing ribbon
Syringes
Blunt needles
Towels and washcloths
Magnetic ear electrodes
Alcohol cleaning wipes
Diamond bands
Hand sanitizer

-

Electronics
TM
Laptop computer with WAVi desktop software
USB mouse
Electronic processing unit (EPU)
USB mini-B cable for EPU
Headphones
3.5mm auxiliary cable for headphones

Solutions
- NuPrep® skin prep gel
- Conduction cream
- 0.9% sodium chloride saline solution

-

Documentation Systems
Instruction manual
Quick setup and scan guide
Cloud instruction manual
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Figure 5
EEG Headset: WAVi MedicalTM System (Boulder, CO)

Note: The soft closed-cell resin-based headset used for conducting EEG-based neurocognitive
assessments with the WAVi MedicalTM system, size small.
Figure 6
Standard 10-20 EEG Montage

Note: The standard 10-20 EEG montage used for EEG electrode placement.
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Figure 7
WAVi MedicalTM System (Boulder, CO) eSocs

Note: Three dry eSocs (left) and a tray of 20 saline moistened eSocs (right) used to conduct the
electrical EEG signal from the participant’s scalp to the WAVi MedicalTM headset.
The use of saline-moistened eSocs eliminates the need for metal electrodes to be secured
next to the scalp or the need for large amounts of conduction gel to be applied (Oakley, 2018).
Saline soaked eSocs serve as the conduction mechanism for electrical energy to be transferred
from the patient’s scalp to the metallic rings located around each receptacle. Figure 8 shows an
eSoc inside a metallic ring of the WAVi MedicalTM EEG Headset.
Figure 8
WAVi MedicalTM eSoc Inside the Metallic Ring of a Headset Receptacle

Note: An eSoc placed inside the metallic ring of a headset receptacle with the blue end facing the
adjustment bands on the outside of the headset and the white end pointing inward.
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These metal rings connect to an electrical conduction strip, embedded within the two layers of
closed-cell resin-based foam, that conducts the electrical signal to the electrical processing unit
(EPU).
The EPU, which amplifies and filters the electrical signal, is connected to the laptop
computer via a universal serial bus (USB) mini-B cable to capture the electrical signal and
display the graphed EEG waveforms in the WAVi MedicalTM desktop software application.
WAVi-based neurocognitive scan assessments are completed in accordance with the WAVi
Instruction Manual Version 0.9.8.17 (see Appendix E). All investigators performing
neurocognitive assessments for the data source study, “Perioperative Brain Health” – IRB
HM20019839, with the WAVi MedicalTM system completed three online competency-based
training modules: 1) Kit Components and Set Up, 2) Headset Contact, and 3) Running the P300
Protocol. Figure 9 depicts a screenshot from one of the online competency-based training
modules.
Figure 9
Online Competency-based Training Module 1

Note: A screenshot from WAVi MedicalTM’s first competency-based training module: Kit
Components and Set Up.
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In addition to the online training, one of the data source study’s investigators traveled to WAVi
MedicalTM, Boulder, CO for in-person training on the device and was approved by the device
manufacturer to train research assistants. Research assistants successfully completed a two hour
in-person, proctored, simulated WAVi MedicalTM setup, preparation, and P300 protocol training
as well as at least two proctored, clinical evaluations of their ability to setup, prepare, and
administer the P300 protocol with the WAVi MedicalTM device.
Performing an EEG assessment with the WAVi MedicalTM platform is a four step
process: 1) equipment set up, 2) participant preparation, 3) donning the headset, 4) performing
the assessment (WAVi MedicalTM, 2017). To set up the WAVi MedicalTM system, an
investigator fills one 5cc syringe with 0.9% saline and one 5cc syringe with
electroencephalogram (EEG) conduction cream (WAVi MedicalTM, 2017). The investigator
opens one tray of 20 WAViTM eSocs and pours approximately 25ml of normal saline over the
eSocs in the tray. The WAViTM desktop application is accessed on a secure, password protected
study laptop (e.g., Dell©, Latitude 3190) in airplane mode (i.e., with WiFi disabled). The
investigator connects the EPU to the study laptop via a USB mini-B cable and clicks the +New
Patient button in the WAViTM desktop application.
The participant is asked to remove all hair accessories (e.g., clips, bobby pins, hair ties,
barrettes) and earrings from the earlobes (WAVi MedicalTM, 2017). The participant’s earlobes
are exfoliated using NePrep® skin prep gel, and a paper towel is provided to clean any residual
NuPrep® off of their earlobes and fingers. The participant’s head circumference is measured
using a sizing ribbon (i.e., a flexible plastic measuring tape with predefined markings) to identify
the appropriate size headset (e.g, small, medium, or large) for the participant. The investigator
places the saline moistened eSocs into the headset receptacles with the blue ends facing the
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flexible rubber diamond-shaped adjustment bands and the white ends pointing inward to make
contact with the participant’s scalp.
Immediately prior to the participant in donning the headset, the investigator places ~0.5cc
of conduction cream on each of the patient’s earlobes, opens the heart rate variability ear clips,
and gently closes one clip onto each of the participant’s earlobes. The investigator then assists
the participant in placing the headset onto the head in a manner similar to wearing a baseball cap.
The investigator ensures optimal headset placement on the participant's head by centering the
heart shaped opening at the front of the headset over the participant ’s nasion (i.e., bridge of the
nose). The heart rate variability ear clips are then connected to the EPU, and the EPU is
connected to the laptop computer. A pair of soft, cushioned headphones are placed on top of the
headset over the participant’s ears and connected to the EPU. The headset is then visually
inspected to ensure that the white tips of the eSocs make contact with the participant’s scalp.
If poor scalp contact is identified, the investigator augments eSocs with poor contact by
repositioning the headset, gently brushing a small amount of hair away from any eSOCs with
poor contact (WAVi MedicalTM, 2017). The investigator then clicks the +Headset Contact button
in the desktop application and inspects for adequacy of the acquired electrical signal from all 20
electrode sites. Sites with sufficient scalp contact and adequate electrical signal are highlighted
as yellow or green in the desktop application, sites with a poor signal that require contact
adjustment are highlighted red. Figures 10 and 11 show screenshots of the software’s contact
feedback system. Visual inspection and electrode augmentation steps, such as applying a small
amount of either saline or conductive cream underneath eSoc sites with a poor signal (i.e., those
highlighted red), are repeated until an adequate signal is confirmed at all sites (WAVi
MedicalTM, 2017). This process can be completed in less than five minutes.

49

Figure 10
Desktop Application Electrode Contact Assessment Page--Good Contact

Note: Electrode sites with sufficient scalp contact and adequate electrical signal are highlighted
as yellow or green.
Figure 11
Desktop Application Electrode Contact Assessment Page--Poor Contact

Note: Electrode sites with sufficient scalp contact and adequate electrical signal are highlighted
as yellow or green, sites with poor contact are red, and sites that that are yet to be assessed are
gray.
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To perform a neurocognitive assessment, the investigator ensures that the computer
mouse is located under the participant’s dominant hand and initiates the "WAVi Performance"
protocol within the desktop application (WAVi MedicalTM, 2017). The WAVi Performance
protocol consists of a series of 3 EEG-based neurocognitive assessments: 1) a one-minute
baseline eyes closed raw-wave EEG assessment, 2) a four-minutes eyes closed P300 assessment,
and 3) a one-minute eyes open tracking assessment. Figure 12 shows an individual participating
in neurocognitive assessment, and Figure 13 displays a screenshot of the WAVi MedicalTM
software during a one-minute eyes open tracking protocol.
Figure 12
Person Participating in Neurocognitive Assessment

The WAVi MedicalTM system is designed to automatically detect and report artifact in the
EEG signal. Artifact is an erroneous EEG signal derived from extra-neural sources (e.g., patient
movement). Artifact is indicated by the red and blue coloration on EEG waveforms and as red
highlighting over respective sites on the 10-20 montage map. Figure 13 illustrates this artifact
detection as red and blue coloring of artifact in the EEG signal.

51

Figure 13
One-minute Baseline Eyes Closed Raw-wave EEG Assessment

Note: Artifact is noted as red and blue coloration in FP1 and F8 waveforms (left side of image)
and red highlighting over the F8 site on the 10-20 EEG montage (right side of image).
One neurocognitive assessment attainable with the WAVi MedicalTM system is the
previously validated auditory P300 AEPs. To perform the four-minutes eyes closed P300
assessment using the WAVi MedicalTM system, the investigator explains the auditory P300 Eyes
Closed test to the participant: "During the test you will hear two different audible tones, a
common low-pitched tone and a rare high-pitched tone. When you hear the rare, high-pitched
tone, click the mouse button." The investigator provides the participant with a brief, < 30 second
practice session and then selects the "P300 Eyes Closed Protocol" within the WAVi MedicalTM
desktop application. During the test, the participant is presented with 200 baseline (i.e., lowpitched) tones and 40 oddball (i.e., high-pitched) tones over four minutes. Following the test,
EEG data is reviewed by the investigator for signal quality. If data quality is acceptable, the test
is complete. If data quality is unacceptable, the test is repeated one additional time.
P300 event-related evoked response tests can be used as a neurophysiological marker for
even mild neurocognitive disorders (Levada et al., 2016). These assessments utilize an oddball
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paradigm to evaluate the brain’s response to a novel stimulus (van Dinteren et al., 2014). The
term “oddball paradigm” refers to the presentation of a randomly interspersed (i.e., oddball)
auditory stimulus (e.g., a high-pitched tone) presented within a series of background baseline
auditory stimuli (e.g., low-pitched tones) (van Dinteren et al., 2014). Healthy brains process and
respond to the oddball stimulus, or high-pitched tone, differently than unhealthy brains. When a
healthy brain is presented with an oddball stimulus, the amplitude (i.e., size) of graphed
waveforms of the brain’s electrical activity are expected to be larger than those produced by an
unhealthy brain, and the latency (i.e., a graphed representation of the time required for signal
conduction among brain cells) is expected to be shorter.
Brain power and cognitive resources are associated with signal amplitude (i.e., power in
microvolts) on EEG (van Dinteren et al., 2014). Brain speed and efficiency are associated with
signal latency (i.e., delay in milliseconds) on EEG (van Dinteren et al., 2014). The graphed
waveform changes identified on EEG following the presentation of an oddball stimulus often
present approximately 300 milliseconds after the stimulus is presented. For this reason, these
waveforms are referred to as P300 waveforms and the assessment as a P300 auditory evoked
potential. However, the waveform change may present with varying degrees of latency 200-500
milliseconds after an auditory stimulus is presented depending on an individual’s age, gender,
and brain health (Sur & Sinha, 2009; Uvais et al., 2018). Additionally, the amplitude (i.e., size)
of the P300 waveform varies with cognitive resources (Levada et al., 2016). Such variations in
amplitude and latency of the P300 waveform are associated with alterations in brain health
(Levada et al., 2016; Melynyte et al., 2018; Sur & Sinha, 2009; Uvais et al., 2018).
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P300 Waveforms
The P300 waveform is a large positive waveform extracted from the EEG signal in
response to an oddball paradigm during an auditory-evoked response test (van Dinteren et al.,
2014). An auditory evoked response oddball paradigm consists of the presentation of a randomly
interspersed oddball target auditory stimulus (e.g., high-pitched tone) within a series of common
background baseline auditory stimuli (e.g., low-pitched tones). Even though the P300 waveform
represents a positive change in amplitude from baseline, the waveform is classically graphed as a
downward deflection from baseline. See Figures 14-17.
Figure 14
Four-minute Eyes Closed P300 Assessment

Note: The black vertical line overtop the EEG waves (left side of image) denotes the presentation
of a common auditory stimulus. The redline overtop the EEG waves denotes the presentation of
an oddball auditory stimulus. The green line overtop the EEG waves denotes the participant’s
physical response (i.e., mouse button click). Artifact is identified as red and blue coloration of
the FP1 and F8 waveforms (left side of image).
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Figure 15
Illustrated Event Related Response Test, Baseline Waveform, & P300 Waveform

Note: An illustrated comparison of the differences observed in the P300 waveform
following the presentation of an oddball stimulus versus a background stimulus. Image adapted
from van Dinteren et al. (2014).
Figure 16
Average P300 Waveform Captured at a Single Site (Pz)

Note: A screenshot of data review following a four-minutes eyes closed P300 assessment.
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Figure 17
Average P300 Waveforms Captured at All 10-20 EEG Montage Sites

Note: FP1 and FP8 do not display waveforms in this image because the software’s auto artifact
detection system identified an insufficient number of adequate P300 waveforms at the FP1 (8/40)
and F8 (5/40) locations.
P300 Changes Associated with Altered Neurocognitive States
Changes in the amplitude and latency of the P300 waveform are associated with altered
neurocognitive states (Polich, 2004; Sur & Sinha, 2009; Clayton et al. 2020). Specifically,
reduced P300 amplitude and prolonged P300 latency have both been associated with
neurobiological vulnerabilities including mild cognitive impairment, Alzheimer’s disease, and
dementia (Egerházi et al., 2008; Hedges et al., 2016; Medvidovic et al., 2013; Uvais et al., 2018;
Yilmaz et al., 2017).
Yener et al. (2013) demonstrated that event-related evoked response tests can be used to
detect mild cognitive impairment. Krishnamurthy et al., (2019) reported that auditory evoked
P300 tests can be used to identify subclinical cognitive impairment in patients with chronic
obstructive pulmonary disease (COPD). Yilmaz et al. (2017) demonstrated that auditory evoked
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P300 tests provide a diagnostic tool for mild cognitive impairment in patients with Parkinson’s
disease. Patients with mild cognitive impairment demonstrated prolonged P300 latency and often
(i.e., 35% of the time) a total loss of the P300 amplitude relative to patients without mild
cognitive impairment (Yilmaz et al., 2017). Egerházi et al., (2008) reported that P300 latency
was significantly prolonged in patients with mild cognitive impairment with cerebral atrophy as
well as in patients with both vascular and Alzheimer’s dementia.
Parra et al. (2012) reported that P300 is a “very useful method for the preclinical
assessment of [Alzheimer’s disease], particularly in populations with low socioeconomic and
educational levels.” Meta-analysis and meta-regression of 646 participants from twenty P300
studies identified a reduced P300 amplitude in participants with Alzheimer’s disease versus
healthy controls (Hedges et al., 2016). Additionally, recent meta-analyses identified that P300
latencies were prolonged in patients with mild cognitive impairment, relative to healthy controls,
and prolonged in patients with Alzheimer’s disease relative to patients with mild cognitive
impairment (Gu & Zhang, 2017; Howe et al., 2014; Jiang et al., 2015; Morrison et al., 2018).
This data indicates that auditory evoked P300 tests may have clinical utility as an identification
tool, differential biomarker, and possibly predictive metric for the progression of neurocognitive
impairments (Gu & Zhang, 2017; Howe et al., 2014; Jiang et al., 2015; Morrison et al., 2018).
Montreal Cognitive Assessment (MoCA)
MoCA version 8.1 (see Appendix A) is considered to be the gold standard rapid
screening tool for identifying mild cognitive impairment (Nasreddine et al., 2005). MoCA is a
single page assessment instrument used to evaluate a participant’s performance on a battery of
neurocognitive tests. The assessment takes approximately 15 minutes to administer. The exact
duration of the assessment depends on how long it takes a participant to complete each test. The
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neurocognitive tests included in MoCA are: three visuospatial drawing tests, one animal naming
test, one word list memory test, three attention related tests (e.g., digits, letters, and subtraction),
two language tests, one abstraction test, one delayed recall test, and one orientation test. During
the assessment, the administrator remains present with the participant to record and interpret the
results of each test in real time. If the participant completes a given test without difficulty, they
receive a point value for that test. Point values for each test range from one to six. The
participant’s final MoCA score is the summation of all individual test scores. The final MoCA
score ranges from 0-30 with higher scores indicating a higher level of cognitive function.
A MoCA score between 26-30 indicates normal cognitive function (Nasreddine et al.,
2005). A MoCA score between 18-25 indicates mild cognitive impairment. This range is
classified as a MoCA severity level one. A MoCA score 10-17 indicates moderate cognitive
impairment. This range is classified as a MoCA severity level two. A MoCA score below 10
indicates severe cognitive impairment. This range is classified as a MoCA severity level three.
Styra et al. (2019) reported that MoCA scores ≤ 15 are predictive of POD. P300 waveform
deformities (e.g., prolonged latency and decreased amplitude) reportedly correlate with MoCA in
patients with idiopathic inflammatory-demyelinating diseases (Zeng, et al., 2017). However, no
relationship has been established between P300 and MoCA in the perioperative setting.
Nasreddine et al. (2005) reported a 90% sensitivity and 100% specificity for MoCA to
diagnose mild cognitive impairment in older persons in the research setting when evaluating
Caucasian older adults. However, Berger et al. (2018) reported that there is insufficient data to
report sensitivity and specificity for MoCA in the perioperative setting and that MoCA has an
inherent education bias. Rossetti et al. (2017) identified that several components of the MoCA
and previously established cut-off points for cognitive impairment are not well suited for African
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Americans. In a sample of over 1,000 community-dwelling African Americans with an average
age of 49 years and no subjective cognitive complaints, the mean MoCA score was 22 (Rossetti
et al., 2017). In this sample, 72% of participants were unable to complete the cube drawing task,
66% of participants recalled fewer than 4/5 delayed free recall words, 63% were unable to
complete the sentence repetition task, and 45% failed the abstraction portion of the assessment
(Rossetti et al., 2017). These factors all present challenges for the use of MoCA as a routine
clinical preoperative neurocognitive screening tool as MoCA may underestimate neurocognitive
function in African American patients (i.e., MoCA scores may be lower for African Americans
than for Caucasians with an equivalent level of cognitive function).
Mini-Cog©
Mini-Cog© (see Appendix B) is a brief neurocognitive screening tool with a two-part
empirical scoring algorithm: a 3-word recall and a clock drawing test (Borson et al., 2003). The
Mini-Cog© is administered in approximately three minutes and is used to detect cognitive
impairment in older adults. Administration of the Mini-Cog© is a simple four step process:
1) Gain the patient’s attention by stating “What we’re going to do next will take some
concentration. Ready?”
2) Initiate the 3-word recall task by saying “I am going to say three words that I want you
to remember now and later. The words are banana, sunrise, chair.”
3) Provide a sheet of paper with a circle already drawn for the patient (See Appendix B)
and ask the participant to “Please draw a clock in the circle…put all the numbers in the
circle.” After numbers have been placed in the clock, say “Now set the hand to show ten
past eleven.”
4) Say “What were the three words I asked you to remember?”
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The Mini-Cog© is scored on a scale of 0-5. One point is awarded for each of the three
words that the participant recalls. Two points are awarded for a normal clock, and no points are
awarded for an abnormal clock. A normal clock presents with all numbers (1-12) placed in the
correct order and direction, one hand pointing to the number 11 and one hand pointing to the
number two. A score ≥ 3 signifies a reduced probability of dementia but does not exclude
cognitive impairment (Borson, 2021). Mini-Cog© is a validated screening tool for both dementia
and mild cognitive impairment in older participants (Borson et al., 2003; Steenland et al., 2008).
However, this simple assessment tool provides only a rough estimate of gross cognitive
dysfunction. Mini-Cog© interpretation guidelines state “[a] total score of 3, 4, or 5 indicates
lower likelihood of dementia but does not rule out some degree of cognitive impairment. The
Mini-Cog© is not a diagnostic test for Alzheimer’s disease or any other dementia or cause of
cognitive impairment. Diagnosis of brain disorders that cause cognitive impairment requires a
medical examination and additional examinations” (Borson, 2021).
Confusion Assessment Method (CAM)
CAM is a validated tool used by non-psychiatric providers (e.g., bedside nurses) to screen
patients for POD by assessing for: acute onset, inattention, disorganized thinking, altered
consciousness, disorientation, memory impairment, perceptual disturbances, psychomotor
retardation, and altered sleep-wake cycles (Inouye, 2003). Inouye (2003) recommends that CAM
assessments be based upon a standardized interview between the participant and the investigator.
Inouye (2003) suggests the administration of Mini-Cog© be used as the standardized interview.
CAM is considered to be the gold standard screening tool for delirium identification (Inouye,
2003). CAM has been used for delirium screening in over 250 studies and reportedly has a 94100% sensitivity and 90-95% specificity for identifying delirium in the research setting (Inouye,
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2003). However, in routine clinical practice, less than 50% of ICU patients with delirium are
identified by CAM (Soja et al., 2008). This may be due to the extensive and recurrent training
required to maintain high inter-rater reliability and the significant staff turnover reported among
ICU nurses (Milkey et al., 2019). Similar limitations could be expected if routine postoperative
CAM assessments were performed on postsurgical recovery units.
Chapter Summary
Perioperative neurocognitive disorders are a major brain health related concern for older
surgical patients (American Society of Anesthesiologists, 2019; Berger et al., 2018; MahannaGabrielli et al., 2019). Some researchers believe these disorders to be the result of
neurobiological alterations sustained from surgery and anesthesia, yet others believe them to be a
post hoc, ergo propter hoc misattribution fallacy (Avidan & Evers, 2016; Berger et al., 2018;
Mahanna-Gabrielli et al., 2019; Jin et al., 2020). A decade after Crosby et al. (2011) lamented
“… that we currently make no effort to identify [older patients with a vulnerable brain state]
preoperatively…” anesthesia providers are beginning to incorporate questionnaire-based
neurocognitive assessments into the preanesthetic assessment at some academic medical centers
(p. 1267; Mahanna-Gabrielli et al., 2019; Decker et al., 2020). However, none of these tools are
routinely used for perioperative neurocognitive assessment due to validity, reliability, and
practicality concerns (Berger, et al., 2018).
POD, the first acute event of neurocognitive impairment following surgery and
anesthesia, is the most prevalent complication experienced by older adult patients (American
Geriatrics Society, 2015; American Society of Anesthesiologists, 2019). POD distresses patients,
their loved ones, and care providers, and is associated with inferior functional recovery and
increased healthcare spending (Hernandez et al., 2017; Hshieh et al., 2017; Inouye et al., 2014;
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Zywiel et al., 2015). Baseline cognitive function is a strong, independent predictor for POD in
older surgical patients, and POD is believed to be preventable in up to 40% of patients (Culley et
al., 2017; Siddiqi et al., 2016). Perioperative patient outcomes may be enhanced by improving
baseline neurocognitive assessments in order to better identify preexisting neurocognitive
impairment and risk-stratify patients. EEG-based auditory evoked P300 tests may have clinical
utility as an identification tool, differential biomarker, and possibly predictive metric for the
progression of perioperative neurocognitive impairments (Gu & Zhang, 2017; Howe et al., 2014;
Jiang et al., 2015; Morrison et al., 2018).
Over 50% of patients who experience POD present with signs of delirium on
postoperative day one (Iamaroon et al., 2020; Lin et al., 2016). The most common presentation
of delirium, the hypoactive form, is more challenging to identify in clinical practice and often
goes undiagnosed (Collins, 2010; Hosker & Ward, 2017). When gold-standard delirium
assessment tools (e.g., CAM) are incorporated into routine clinical practice, less than 50% of
patients with delirium are diagnosed (Soja et al., 2008). Early delirium detection is critical
because prolonged duration of delirium is associated with increased treatment difficulty (Mulkey
et al., 2019). EEG-based neurocognitive assessments can reportedly identify subsyndromal
delirium (i.e., neurocognitive changes that portend delirium) prior to the presentation of clinical
signs and symptoms (Mulkey et al., 2019)
However, traditional EEG assessment modalities are not easily incorporated in routine
clinical practice (Inouye et al., 2014; Mulkey et al., 2018; Mulkey et al., 2019). The WAVi
MedicalTM system is an FDA-cleared POC EEG hardware and software system designed to
rapidly perform EEG-based P300 AEP neurocognitive assessments (WAVi, 2019).
Neurobiomarkers obtainable with this device may have clinical utility for identifying, predicting,
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and tracking perioperative neurocognitive disorders. However, the utility of the WAVi
MedicalTM system has never been evaluated in the perioperative setting.
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Chapter 3: Theoretical Framework
“The secret of quality is love.” -Avedis Donabedian
Chapter Overview
Chapter three presents this study’s guiding theoretical framework, Donabedian’s
Theoretical Model for Evaluating the Quality of Medical Care. The chapter begins with a brief
overview of the origin and history of Donabedian’s model. The suitability of the model for this
study is discussed. Studies applying and validating the Donabedian model in the perioperative
setting are identified.
Introduction
Over 50% of surgical procedures performed in the United States (U.S.) are performed on
patients over the age of 65 years (Yang et al., 2011). A significant number of these patients may
subsequently develop postoperative delirium (POD). POD, a state of disorganized thinking and
inattention, complicates the recovery process and is associated with increased length of
hospitalization, increased morbidity and mortality, progression to delayed or incomplete
neurocognitive recovery, and the subsequent development of dementia (Saczynski et al., 2012;
Koster et al., 2012; Hshieh et al., 2017; Sprung et al., 2017; Aranake-Chrisinger & Avidan,
2017). The American Society of Anesthesiologists’ Perioperative Brain Health Initiative
advocates for research aimed at discovering novel POD identification, mitigation, and prevention
strategies (American Society of Anesthesiologists, 2019). No rapid, reliable, practical, sensitive
and specific assessment of neurocognitive function currently exists to preoperatively identify atrisk patients, recognize POD in the early postoperative period, or track POD in older surgical
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patients. This study is designed to analyze EEG-based neurocognitive assessment data captured
in the perioperative setting with an innovative POC EEG hardware and software system, WAVi
MedicalTM to evaluate the potential clinical utility of neurobiomarkers obtained with the device.
These neurobiomarkers may one day be used to guide the clinical care of older surgical patients
and reduce the incidence and/or severity of perioperative neurocognitive disorders (e.g., POD).
The study was guided by Donabedian’s Theoretical Model for Evaluating the Quality of
Medical Care (Donabedian, 2005). Donabedian’s care model is the most commonly used
theoretical framework for evaluating the quality of health care services (Ayanian and Markel,
2016). Donabedian first published his seminal work in The Milbank Quarterly, a
multidisciplinary journal of population health and health policy, in June 1966 (Berwick & Fox,
2016). The paper was reprinted verbatim in the same journal in 2005 (Berwick & Fox, 2016).
Donabedian (2005) put forth three concepts (structure, process, and outcome) as guiding
principles for quality improvement. These concepts now serve as the constructs of Donabedian’s
theoretical model. The three key domains of Donabedian’s quality improvement model are
shown in figure 18.
Figure 18
Donabedian’s Theoretical Model for Evaluating the Quality of Medical Care

Donabedian’s (1966) theoretical model for evaluating the quality of medical care was a good fit
for this study because it is descriptive, explanatory, accurate, practical, simple, consistent, and
acute (Goes & Simon, 2012).
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Descriptive & Explanatory
Goes and Simon (2012) state that a theory should explain the “Who? What? When?
Where? How? [and] Why? about a situation or phenomenon” (p. 2). Donabedian’s (2005) model
explains all six questions in regards to this study. Three of these questions (i.e., Who?—older
surgical patients When?—perioperative period Where?—PACE and post-surgical follow-up) are
addressed within the construct of structure. What—method of neurocognitive assessment—P300
versus MoCA is addressed by the construct process. Why— to identify novel neurocognitive
assessment tools and biomarkers for predicting, identifying, and tracking perioperative brain
health in older surgical patients—can be categorized under the construct outcome.
Accurate
Accuracy can be evaluated by “investigating what a variety of experts say regarding the
theory” (Goes and Simon, 2012, p. 2). Donabedian’s (2005) model has been applied, tested,
retested and referenced by researchers from a variety of disciplines for over fifty years (Berwick
& Fox, 2016). Within that time frame the model’s creator authored four books on quality
assessment in medical care including: 1) The Definition of Quality and Approaches to Its
Assessment, 2) The Criteria and Standards of Quality, 3) The Methods and Findings of Quality
Assessment and Monitoring: An Illustrated Analysis, and 4) An Introduction to Quality
Assurance in Health Care (Berwick & Fox, 2016).
Practical
Multiple real-world applications of Donabedian’s (2005) model are identifiable in the
literature. At least six studies incorporated the model to guide perioperative research. Rose et al.
(2019) applied the model to guide an integrative review of the literature to identify best practices
for postoperative patient handoff. Specifically, the authors used Donabedian’s model to organize
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and synthesize seventeen articles on information transfer during patient handoff from surgical
and anesthesia teams to the postoperative care unit (PACU) teams. Figure 19 shows Rose et al.’s
(2019) use of the model.
Figure 19
Patient Handoff Structures, Processes, & Outcomes Based on Donabedian’s Model

Note: Image adapted from Rose et al. (2019).
Jeffcott et al. (2009) and Gardener et al. (2014) also employed Donabedian’s model to evaluate
quality of care of patient handoff and other nursing services.
Centurion et al. (2018) applied the model to identify the minimum standard of care when
performing surgery with limited resources following natural disasters in low- and middle-income
countries. The authors identify that Medécins Sans Frontières (MSF) (i.e., Doctors Without
Borders) has been providing surgical care services in low- and middle-income countries for 45
years. Over this time, the organization has utilized Donabedian’s model to measure the quality of
these services in various locations around the globe. As an example, MSF evaluates human
resources, infrastructure (e.g., water and electricity supply), biomedical devices, and the supply
of medications using the structural component of Donabedian’s model (Centurion et al., 2018).
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Moore et al. (2015) validated the model for assessing quality of care improvement in
trauma care services in a multicenter retrospective cohort study. Prior to Moore et al.’s (2015)
study that statistically evaluated correlation between process and outcomes, Donabedian’s model
had already been widely adopted by trauma care providers to guide quality improvement
projects. The authors identified that trauma centers with appropriate structures tend to have
strong clinical processes that positively impact patient outcomes (Moore et al., 2015).
Tsai et al. (2013) used Donabedian’s model to guide their investigation of the
readmission rates of surgical patients. The authors incorporated Donabedian’s structure, process,
and outcome components of quality of care to investigate 30-day readmission rates of 479,471
Medicare patients from 3,004 different hospitals following a variety of surgical procedures
including: coronary artery bypass graft (CABG), pulmonary lobectomy, endovascular abdominal
aortic aneurysm repair (EVAR), open abdominal aortic aneurysm repair (AAA), colectomy, and
hip replacement.
Birkmeyer et al. (2004) adopted the Donabedian model to evaluate quality of surgical
care services. The authors noted that hospitals are increasingly under pressure to evaluate and
demonstrate quality of care as it becomes increasingly apparent that patient outcomes vary
nationally by surgeon and hospital. Noting the wide variation of quality improvement metrics
used in prior studies, the authors sought to report on the potential advantages and disadvantages
of each after classifying metrics as either structure, process, or outcome in an effort to identify a
focus for future investigation. Figure 20 depicts an example of how these authors incorporated
the model.
Hannan et al. (2001) employed the model to guide a retrospective cohort investigation of
outcomes following carotid endarterectomy surgery among 3,644 patients. As a result of the
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Figure 20
Example of Structures, Processes, & Outcomes of Surgical Care

Note: Image adapted from Birkmeyer et al. (2004).
noted variation in practice patterns and patient outcomes, the authors sought to identify which, if
any, processes led to superior inpatient outcomes. The authors identified that when a
combination of processes (e.g., eversion endarterectomy, protamine, or shunts) were utilized,
fewer patients had adverse outcomes (OR=0.42, P=0.006).
Simple
Donabedian’s (2005) unidirectional model is constructed of three simple concepts:
structure, process, and outcome. All three constructs are capable of influencing quality of care.
For this study, structure remained constant, and alternative processes (i.e., neurocognitive
assessment methods) were evaluated to determine if P300 metrics potentially predict, identify,
and track an outcome, perioperative neurocognitive disorders (e.g., POD).
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Consistent
Both internal and external consistency of Donabedian’s (2005) model have been
considered. Internal consistency refers to the inherent logical nature of a theory, and external
consistency references a given theory in relation to other theories. Donabedian’s (2005) model is
logical in the context of this study. Within a defined and relatively consistent structure, changing
a clinical process could logically affect an outcome. Moore et al. (2015) validated the external
consistency of the Donabedian model for trauma care. The authors demonstrated statistically
significant correlation between a process (e.g., conformity to 15 implemented quality
improvement metrics) and two outcomes (e.g., length of stay (r = - 0.27) and readmission (r = 0.33)).
Acute
Goes and Simon (2012) describe an acute theory as one that is able “to provide insight
into an otherwise complex problem” (p. 3). Perioperative neurocognitive disorders are quite a
complex problem. The causative etiology of POD is unknown and likely multifactorial (Wu et
al., 2019). What is known is that baseline cognitive function is a strong, independent predictor
for POD in older surgical patients (Adegowa et al., 2018). However, no rapid, reliable, practical,
and highly sensitive and specific neurocognitive assessment tool is currently available to
anesthesia providers for routine clinical care.
As previously mentioned, Crosby et al. (2011) lamented this problem:
…that we currently make no effort to identify [older patients with a vulnerable brain
state] preoperatively is an embarrassing state of affairs considering that the brain is a
principal target of general anesthetic agents, the field of anesthesiology champions
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thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is
so common and costly (p. 1267).
To address this gap, this study employed Donabedian’s (2005) model.
Application of Donabedian’s Quality of Care Model
Donabedian’s (2005) model clearly identifies and operationalizes three categories for
consideration when seeking to improve patient outcomes in health care research. Structure refers
to the physical and organizational characteristics where healthcare occurs. In this study, the
structure referenced the perioperative setting (i.e. specifically, the preoperative assessment,
communication, and education (PACE) clinic and the post anesthesia care unit (PACU)). Process
refers to the manner in which a system or procedure works to provide a desired outcome, and
outcome refers to the impact an intervention has on patients. In this study, the process-outcome
relationship being investigated was the utilization of EEG-based P300 neurocognitive metrics
versus best medical practice (e.g., MoCA) to identify and track perioperative neurocognitive
states in older surgical patients. See Figure 21.
Figure 21
Specific Structures, Processes, & Outcomes for This Study

71

Specific Aims & Hypotheses
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300 latency
(i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’ cognitive
function. This study used regression to understand whether auditory P300 amplitude (in
microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among
older surgical patients as assessed by MoCA. Each variable was considered
independently as they measure two separate constructs of neurocognition, namely
cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between
participants who received two or more potentially neuroprotective multimodal anesthetic
adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did
not.
Hypothesis #3: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a larger positive change in their
P300 amplitude, measured as a pre- to postoperative change score in microvolts.
Hypothesis #4: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in
their P300 latency relative to their baseline, measured as a pre- to postoperative
change score in milliseconds.
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Chapter Summary
Each year, 50% of surgeries in the U.S. are performed on patients over the age of 65
years (Yang et al., 2011). The most common complication experienced by these patients is POD.
POD is a state of confusion and inattention that complicates the recovery process, increases
hospital length of stay, increases patients’ morbidity and mortality risk, and escalates health care
costs (Saczynski et al., 2012; Koster et al., 2012; Hshieh et al., 2017; Sprung et al.,
2017; Aranake-Chrisinger & Avidan, 2017). Improved neurocognitive assessment tools may
offer anesthesia providers more detailed information on the state of a patient’s brain throughout
the perioperative period. Such information could guide the development of a perioperative brain
health protocol to reduce the incidence and severity of POD in older surgical patients.
This study, guided by Donabedian’s Theoretical Model for Evaluating the Quality of
Medical Care, was designed to analyze the utility of EEG-based neurocognitive assessment data
to perioperatively identify and track neurocognition in older surgical patients. Donabedian’s
model was appropriate for this study because the model is descriptive, explanatory, accurate,
practical, simple, consistent, and acute in identifying links between practice processes and
patient outcomes in the perioperative setting (Birkmeyer et al., 2004; Centurion et al., 2018;
Hannan et al., 2001; Moore et al., 2015; Rose et al., 2019; Tsai et al., 2013).
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Chapter 4: Methodology
Chapter Overview
The purpose of this study was to explore baseline and postoperative neurocognitive
characteristics that may help to establish novel predictive and trend metrics for perioperative
neurocognitive assessment in older surgical patients. As a proof-of-concept study, this research
primarily sought to identify associations that may be useful in generating hypotheses to guide
future research. This study was largely a proof of concept study, due to the small sample size of
records available from the data source study, accepting the impact of sample size on statistical
conclusion validity. The study evaluated the potential for P300 AEPs to recognize and track
perioperative neurocognitive alterations in older surgical patients. The identification,
organization, and analysis of study variables was guided by the three constructs of Donabedian’s
Theoretical Model for Evaluating the Quality of Medical Care: structure, process, and outcome.
Chapter four presents the study’s methodology including: research design, data source, sampling
strategy, and study variables. This chapter describes the study’s data management and analysis
plans in detail, and concludes with a discussion of assumptions, limitations, and the study’s
significance.
Research Design
To evaluate the potential utility of P300 AEPs for assessing and tracking perioperative
brain health in older surgical patients, the following methodology was used. The study employed
a non-randomized, non-experimental, ex post facto secondary data analysis design to 1)
retrospectively compare participants’ P300 AEPs to MoCA scores before surgery and anesthesia

74

and 2) evaluate for mean group differences in pre- and postoperative change scores between
participants who received two or more potentially neuroprotective multimodal anesthetic agents
and those who did not. Secondary data analyses explore research questions by using an existing
data set (Hulley et al., 2013). Secondary data sources may include electronic medical records,
administrative databases, or existing research studies (Hulley et al., 2013). In retrospective
studies, investigators begin with a dependent variable and look backward to determine whether
or not an association exists between the dependent variable and one or more independent
variables (Polit & Beck, 2017). Retrospective designs can be used to identify potentially
predictive factors for an outcome (Polit & Beck, 2017).
Aims & Hypotheses
This study evaluated two specific aims. The first study aim was to evaluate the ability of
participants’ preoperative baseline P300 latency and amplitude to predict participants’ cognitive
function as assessed by MoCA. The second study aim was to evaluate for mean group
differences in pre- to postoperative P300 AEP change scores between participants who received
two or more potentially neuroprotective multimodal anesthetic adjunct medications (e.g.,
lidocaine, ketamine, and magnesium) versus those who did not. Table seven delineates the study
purpose, aims, and hypotheses.
Data Source
Data for this study was extracted from the VCU/VCUHS REDCap® database:
“Perioperative Brian Health” – PID 22988. Data in this database was collected using a
longitudinal, repeated measures design to conduct a prospective observational trial with a set of
pretests and multi-observation post-tests. Figure 22 illustrates the data source study’s research
design.
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Table 7
Study Purpose, Aims, and Hypotheses
Purpose
Explore baseline and
postoperative
neurocognitive
characteristics that
may help to establish
novel predictive and
trend metrics for
perioperative
neurocognitive
assessment in older
surgical patients

Aims
Aim1: Evaluate the ability
of participants’ preoperative
baseline P300 latency and
amplitude to predict
participants’ cognitive
function.
Aim2: Evaluate for group
differences in pre- to
postoperative P300 AEP
change scores between
participants who received
two or more potentially
neuroprotective multimodal
anesthetic adjunct
medications versus those
who did not.

Hypotheses
H1: Lower P300 amplitude will be
predictive of lower MoCA scores.
H2: Higher P300 latency will be
predictive of lower MoCA scores.
H3: Participants who received two or
more potentially neuroprotective
multimodal anesthetic agents will
demonstrate a larger positive change
in their P300 amplitude, measured as
a pre- to postoperative change score
in microvolts.
H4: Participants who received two or
more potentially neuroprotective
multimodal anesthetic agents will
demonstrate a smaller degree of
prolongation in their P300 latency
relative to their baseline, measured as
a pre- to postoperative change score
in milliseconds.

Figure 22
Research Design for the Perioperative Brian Health Prospective Observational Trial
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The “Perioperative Brian Health” – PID 22988, database is being created as part of an
ongoing interdisciplinary perioperative brain health study with multiple research aims that are
separate from this study. The database currently contains perioperative neurocognitive
assessment records for 20 participants. Not all participants’ records in the database met the
eligibility criteria for this study. The “test” or intervention refers to participants’ scheduled
elective surgery and anesthetic. Preoperative baseline neurocognitive assessments were
completed using the WAVi MedicalTM software and hardware system and MoCA. Figure one
depicts the WAVi MedicalTM neurocognitive assessment platform. Appendix A presents the
MoCA.
WAVi MedicalTM scans were conducted and interpreted by trained research team
members. WAVi MedicalTM scans were performed as participants attempted an event-related
response test. During the event-related response test, participants were asked to click a mouse
when they heard a rare high-pitch tone within a series of low-pitch tones. The WAVi MedicalTM
system assessed participants’ neurocognitive activity during the auditory evoked potential testing
and reported quantitative metrics of cognitive performance operationalized as time (in
milliseconds) and voltage (in microvolts).
MoCA assessments were conducted and interpreted by trained research team members.
One of the Perioperative Brian Health study’s (i.e., the data source for this study) investigators
was MoCA-certified to administer and score MoCA assessments. This investigator trained
research assistants to administer the MoCA v8.1 assessment based on Nasreddine’s (2017)
MoCA v8.1 instructions for administering and scoring the MoCA. Research assistants
successfully completed proctored simulated MoCA assessments on one another and at least two
proctored clinical MoCA administrations prior to independently administering the MoCA
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assessment to study participants. Nasreddine’s (2017) MoCA v8.1 standardized MoCA
administration script was used for all MoCA assessments. The MoCA certified investigator
scored all assessments.
Following surgery and anesthesia, participants underwent postoperative neurocognitive
assessments using the WAViMedTM system, Mini-Cog©, and CAM. All assessments were
conducted and interpreted by trained research assistants. The CAM Short Form was used by all
evaluators. The Mini-Cog©, along with the WAVi P300 Assessment, was used as a standardized
interview upon which to conduct the CAM evaluation as recommended by Inouye (2003).
Appendix B presents the Mini-Cog© assessment. Appendix C presents the CAM Short Form.
Appendix D presents the WAViMedTM system’s patent.
Target & Accessible Populations
The target population for this study was surgical patients over the age of 60 years
presenting for elective, non-cardiac surgery and anesthesia. The accessible population was a
convenience sample of surgical patients over the age of 60 years presenting to the VCU/VCUHS
PACE clinic for preoperative evaluation and subsequently for surgery and anesthesia who
underwent perioperative neurocognitive assessment while enrolled in the study “Perioperative
Brain Health” – IRB HM20019839. VCU/VCUHS is a Level I trauma and regional referral
center located in Richmond, Virginia that performs over 24,000 surgeries annually.
VCU is an urban public research university ranked among the top 100 research
universities by the National Science Foundation and received over 335 million dollars in
research funding in 2020 (Annual Report, 2020). This setting increased the likelihood that data
source study’s findings would be generalizable to a wide variety of surgical procedures and
across a large spectrum of patient conditions and comorbidities. Richmond, Virginia’s
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population by race is: 48% Black or African American, 40% White or Caucasian, 6% Hispanic
or Latino, 4% 2 or more races, 2% Asian, and <1% other (U.S. Census Bureau, 2019). The U.S.
population is 60% White or Caucasian, 18% Hispanic or Latino, 13% Black or African
American, 6% Asian, 2% having a combined two or more races, and <1% other (U.S. Census
Bureau, 2019). Therefore, generalizability of the study results to some ethnic groups (e.g.
Hispanic or Latino) in other regions of the United States may be limited by the research setting.
Sampling Strategy
For secondary data analysis, the sampling strategy is the method by which study
participants are identified from the sampling frame (i.e., the available database) (Hulley et al.,
2013). For this study, the VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID
22988 was the sampling frame. Available participants in this database underwent a variety of
elective non-cardiac surgeries (e.g., orthopedic, urologic, oncologic, and general) and anesthesia
at VCU/VCHU between November 2020 and April 2021 and participated in the study
“Perioperative Brain Health” – IRB HM20019839. The number of participants in the sample was
limited by the number of participants with complete data records that met this study’s eligibility
criteria. Adequate data to meet study aims was expected as this study was not aimed at testing
efficacy and similar EEG-based delirium studies analyzed data sets of between 12 and 23
participants. (e.g., Evans et al., 2017; Mulkey et al., 2019; Vacas et al., 2016).
The “Perioperative Brain Health” – IRB HM20019839 study employed a convenience
sampling strategy. All initial screening, consent, and evaluation procedures took place in the
VCU Health PACE clinic immediately after the potential study participant completed their
scheduled preoperative anesthetic evaluation appointment. With the approval and collaboration
of the Anesthesiologist Director of PACE, the investigators reviewed the PACE clinic schedule
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each day to identify potential study participants scheduled for their preoperative anesthesia
assessment in the PACE clinic the following day. Immediately following the patient's PACE
clinic visit, PACE clinic staff asked each potential study participant if they would like to speak
with a member of the “Perioperative Brain Health” study team about participating in an
observational research study. Potential study participants were informed about the study by
members of the research team and asked if they would like to participate. If yes, informed
consent was obtained, and initial observations were completed in a PACE clinic exam room.
Eligibility Criteria
Two eligibility criteria were used when identifying study participants from the
VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID 22988 sampling frame.
Eligibility criteria and their rationale for both this study and the data source study are listed in
Table eight.
Table 8
Eligibility Criteria and Rationale
Current proposed study
Inclusion

Exclusion

Data Source
Inclusion

Criteria
Sufficient data record to
meet the aims of this
study.

EEG artifact that
precludes high quality
assessment data (i.e., less
than 30/40 artifact free
P300 waveforms)
Scheduled for an on-site
preoperative anesthesia
evaluation at the VCU
Preoperative Assessment
Communication and

Rationale
A subset of participants in the study data base
did not have adequately complete data records
for analysis due to a combination of factors
including patient safety, patient satisfaction,
and COVID-19 related assessment limitations.
Excessive EEG artifact may render erroneous
P300 data. Therefore, records were excluded if
less than 30/40 artifact free P300 waveforms
were successfully captured during the fourminute oddball paradigm assessment.
1) Brain function assessments were performed
in the PACE clinic rather than the preoperative
holding area so as to not delay the operating
room on the day of surgery
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Table 8 Continued
Inclusion

Education (PACE) clinic
prior to surgery

2) WAVi EEG Brain scans require an in-person
assessment and cannot be performed remotely.

Greater than 60 years of
age

1) The risk of an adult patient experiencing
postoperative delirium (POD) increases with
age
2) The highest risk age group for POD is
greater than 60 years of age.
Duration of anesthesia is associated with an
increased risk of POD.

Anticipated to be under
general anesthesia for
greater than 1 hour
Scheduled for surgery
below the neck

Exclusion

Per the WAVi Instruction Manual (Version
0.9.8.17) "Do not use the WAVi headset on or
near skin that is bruised or weakened due to
either injury or the medical condition of the
patient."
Participants with
Informed consent was required for this study
documented baseline
and participants who are unable to provide
cognitive impairments
informed consent due to a severe baseline
that exclude them from
cognitive impairment would not be able to
providing informed
perform the planned cognitive screening
consent
assessments.
Self-reported inability to The WAVi auditory P300 tests assess the speed
hear stimulus tone
and power with which a patient's brain
differentiates between a high pitched auditory
tone and a low pitched auditory tone. Patients
who were unable to hear these tones were not
able to participate in the WAVi auditory P300
brain assessments.
Positive COVID-19 test
To mitigate the risk of transmitting COVID-19
result within the previous from one participant to another, participants
14 days documented in
with a documented positive COVID-19 test
the patient’s health record result in their health record within the previous
14 days were not eligible to participate.

Power Analysis
Power analysis enables a priori determination of sample size which enhances statistical
conclusion validity and reduces the risk of a Type II error (Polit & Beck, 2017). A priori power
analysis was performed using the Daniel Soper Statistical Power Calculator version 4.0 (Soper,
2021). An effect size of 0.5 was anticipated given the frequency of POD noted in the literature
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(American Geriatrics Society, 2015; American Society of Anesthesiologists, 2019). For the first
study aim, a sample of 15 participants was analyzed. With two predictor variables, each
considered independently as they measure two separate constructs of neurocognition, an
anticipated effect size of 0.5, and α of 0.05, the a priori power of this analysis was calculated to
be 0.94.
For the second study aim, a sample of 10 participants was analyzed in this study. A doubly
multivariate design using a repeated-measures multivariate analysis of variance (MANOVA)
would be the ideal analysis for this aim. However, a priori power analysis indicated that results
were likely to be substantially underpowered. With three predictors (i.e., the DV, the two groups,
and the pre- to postoperative repeated analysis), an anticipated r2 = 0.5, α = 0.05, and n = 10,
power would only be 0.46.
The next best analysis for aim two would be a one-way MANOVA with pre- and
postoperative scores transformed into a single difference score. However, with two predictors
(i.e., the DV, and the two groups), an anticipated r2 = 0.5, α = 0.05, and n = 10, power would
only improve to 0.61. A power of greater than 0.8 is desired to support statistical conclusion
validity (Tabachnick and Fidell, 2013). For this reason, a pair of one-way ANOVA analyses
were planned and conducted for the second study aim. With one response variable, an effect size
of 0.5, and α of 0.05, the a priori power of this analysis was calculated to be 0.8.
Data Management
Electronic study data was stored on a secure password protected university issued laptop
and backed up on a secure password protected university-based cloud storage server. REDCap®
was used to manage all data for this study. Hard copies of data generated during this study were
securely stored in a locked file cabinet and only made accessible to research staff as needed.
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REDCap® is a cloud-based research software platform designed for rapid data collection and
secure data storage (Harris et al., 2009). REDCap® was specifically designed to provide
researchers with an easy-to-use, customizable secure location for the collection, storage and
dissemination of clinical data (Harris et al., 2009). All participants’ protected health information
remained confidential. In addition to the study measures (i.e., WAVi MedicalTM P300 and
MoCA), the following demographic data were collected and recorded for each participant:
American Society of Anesthesiology Classification Score, age, sex, ethnicity, surgical procedure,
length of surgery, primary anesthetic, and the administration of adjunct the potentially
neuroprotective multimodal anesthetic agents under investigation (i.e., magnesium, lidocaine,
and ketamine). Study data were only made available to members of the research team and VCU’s
institutional review board (IRB) upon request. Data that could potentially identify individual
participants (e.g., name, birthdate, date of surgery, etc.) will not be published. REDCap®’s
embedded statistical software was used to perform descriptive statistics of the data set. Study
data was exported from REDCap® into the IBM® Statistical Package for the Social Sciences
(SPSS) version 26.0 to perform multivariate statistical analyses.
Variables & Measures
The predictor variables for the first study aim were auditory P300 amplitude and auditory
P300 latency. The measurement for P300 amplitude was microvolts. The measurement for P300
latency was milliseconds. Measurement data for the aforementioned variables were continuous,
ratio level data. Continuous variables may take on any value of a given scale (Tabachnick &
Fidell, 2013). The precision of measurement for continuous variables is limited by the
measurement instrument as opposed to a scale itself (Tabachnick & Fidell, 2013). Ratio level

83

data is interval data (i.e., each value increment on the measurement scale is equally divided) that
has a natural zero starting point (Tabachnick & Fidell, 2013).
The criterion variable for the first study aim was participants’ preoperative MoCA score.
MoCA is scored on a scale of 0-30 points with a score of 30 representing a correct answer on
each assessment item. The measurement for MoCA score is a whole integer between zero and
30. Data for this variable was continuous, ratio level data.
The dependent variables for the second study aim were participants’ pre- to postoperative
P300 amplitude and P300 latency change scores. The measurement for P300 amplitude was
microvolts. The measurement for P300 latency was milliseconds. The independent variable for
the second study aim was whether or not the participant received two or more potentially
neuroprotective multimodal anesthetic adjunct medications (i.e., lidocaine, magnesium, and/or
ketamine) intraoperatively. The measurement for this variable was YES or NO. Data for this
variable was categorical. Table nine categorizes the study variables.
Table 9
Variables, Measurements, and Data Classification
Study
Aim
1

Variable

MoCA Score

Dependent (DV)
vs
Independent (IV)
DV

Measurement

Data Classification

Whole Integer
(0-30)
Microvolts
Milliseconds
Microvolts

Continuous, Ratio

P300 Amplitude
IV
P300 Latency
IV
2
P300 Amplitude
DV
Change Score
P300 Latency
DV
Milliseconds
Change Score
PNMMAAa
IV
YES / NO
a
potentially neuroprotective multimodal anesthetic adjuncts
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Continuous, Ratio
Continuous, Ratio
Continuous, Ratio
Continuous, Ratio
Categorical

Protection of Human Participants
Data for this study was secondary data collected form the VCU/VCUHS REDCap®
database: “Perioperative Brian Health” – PID 22988. All participant’s protected health
information was kept confidential in accordance with the Health Insurance Portability and
Accountability ACT (HIPAA) of 1996 throughout this study. No personal identifiable patient
information was collected for this study. This study did not require informed consent as it
represented no more than minimal risk to the study patient. All participants whose records were
utilized for this study previously gave informed consent to participate in the study “Perioperative
Brain Health” – IRB HM20019839. The signed IRB approved consent forms for the study
“Perioperative Brain Health” – IRB HM20019839 stated “In the future, identifiers might be
removed from the information you provide in this study, and after that removal, the information
could be used for other research studies by this study team or another researcher without asking
you for additional consent.”
Data Cleaning
After data for this study was exported from REDCap®, variables were named and data
was evaluated as described by Tabachnick and Fidell (2013) chapter four. First, accuracy of the
recorded data was assessed. Next, the data set was evaluated for missing data and would have
been reconciled by performing a value analysis to evaluate for magnitude and patterns of missing
data. Not missing data was identified. Third, data fit was assessed for the assumptions of each
multivariate statistical analysis. Fourth, data would have been transformed if necessary. No data
required transformation. Finally, the data set was evaluated for outliers which would have been
acknowledged and handled as indicated by accepted best statistical practices. No outliers were
identified.
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Descriptive Statistics
Descriptive statistics portray a study’s sample population and use this information to
describe the reference population (Tabachnick and Fidell, 2013). This study generated
descriptive statistics to depict the characteristics of a sample of older surgical patients presenting
for surgery and anesthesia who participated in the study “Perioperative Brain Health” – IRB
HM20019839 and met eligibility criteria for this study. The following descriptive statistics are
reported in chapter five: 1) sample size, 2) age (range and mean), 3) sex (% female vs male), 4)
ethnicity (% African American, Caucasian, Hispanic or Latino, 2 or more races, Asian, and
other), 5) American Society of Anesthesiology Classification Score, 6) surgical procedure
(nominal), 7) length of surgery (range and mean), 8) type of anesthetic (nominal), 9) duration of
anesthetic, and 10) the administration of potentially neuroprotective multimodal anesthetic
adjunct medications (categorical).
Multivariate Statistics
Regression was used in the evaluation of data for the first study aim to assess whether
auditory P300 amplitude (in microvolts) or auditory P300 latency (in milliseconds) predicted
participants’ MoCA scores. Regression was appropriate for this analysis as it aims to create a
linear combination of independent variables that optimally predict a dependent variable and
identify the relative contribution of each independent variable to the total variance explained by
the model. Once collected, data were analyzed for the following eight assumptions prior to
performing regression analysis (Laerd, 2021a):
1. The dependent variable was interval or ratio level data
2. There were two or more independent variables with continuous data
3. Independence of observations was present
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4. Normality was present
5. There was a linear relationship between the two variables
6. Homoscedasticity was present
7. Multicollinearity was absent
8. There were no significant outliers
Assumptions one, two, and three were self-evident from the data set as displayed in tables nine
and 10. Histograms were generated to assess normality. Scatterplots were generated to assess
linearity, homoscedasticity, and outliers. A Pearson correlation matrix was generated to assess
for multicollinearity. The results for assumption testing including histograms, scatterplots, and
SPSS output are discussed and displayed in chapter five. Each variable was considered
independently as they measure two separate constructs of neurocognition, namely cognitive
resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).
The ideal statistical analysis for the second study aim would have been a doubly
multivariate design using a repeated-measures multivariate analysis of variance (MANOVA).
This approach would enable the evaluation of multiple non-commensurate dependent variables
(e.g., P300 latency and P300 amplitude which are measured on different scales: microvolts and
milliseconds respectively) that are repeatedly measured (e.g., pre- and postoperatively)
(Tabachnick and Fidell, 2013). This design enables singly multivariate evaluation of the
between-subjects effect (i.e., those who received potentially neuroprotective multimodal
anesthetic adjunct medications versus those who did not) and doubly multivariate evaluation of
the within-subjects effects (i.e., pre- versus postoperative values of the dependent variables).
This analysis would test for parallelism, flatness, and levels (Tabachnick and Fidell, 2013). Of
these three, parallelism testing would be of the highest utility for this study to evaluate for a
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difference in neurocognitive metrics between participants who received potentially
neuroprotective anesthetics adjuncts and participants who did not. The sample size required for
this analysis is set by the between-subjects effect according to the conditions for MANOVA.
With the current sample size available in the data source study (i.e., postoperative assessment
n=10), results from this analysis were estimated to be substantially underpowered in the a priori
power analysis. For example, with three predictors (i.e., the DV, the two groups, and the pre- to
postoperative repeated analysis), an anticipated r2 = 0.5, α = 0.05, and n = 10, power would only
be 0.46. To support statistical conclusion validity, a power of greater than 0.8 is desired
(Tabachnick and Fidell, 2013). For this reason, a doubly multivariate design using a repeatedmeasures MANOVA was not used for this study as this design uses one degree of freedom
comparing pre- to postoperative scores and one degree of freedom for the two groups.
The second best statistical analysis for the second study aim would have been to conduct
a one-way MANOVA by converting the pre- and postoperative scores into a single difference
score. This would reduce the number of predictors by one and reduce the degrees of freedom
used by one. However, with two predictors (i.e., the DV, and the two groups), an anticipated r2 =
0.5, α = 0.05, and n = 10, power would only improve to 0.61. For this reason, a one-way
MANOVA of difference scores was not used for this study.
A pair of one-way ANOVA analyses were conducted for the second study aim to
determine whether a difference exists in pre-and postoperative P300 amplitude (in microvolts)
and P300 latency (in milliseconds) change scores between participants who received potentially
neuroprotective multimodal anesthetic adjunct medications and those who did not. ANOVA is
appropriate for this analysis because it aims to determine if a statistically significant difference
exists between the means of two or more independent groups, minimizes the effect of the degrees
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of freedom, and maximizes the power for a small sample (Tabachnick and Fidell, 2013). With
one response variable, an effect size of 0.5, and α of 0.05, the a priori power of this analysis was
calculated to be 0.8. After being collected, data was analyzed for the following six assumptions
prior to performing an ANOVA (Laerd, 2021b):
1. The dependent variable was interval or ratio level data
2. The independent variable consisted of two or more independent, categorical groups
3. There was independence of observations
4. There were no significant outliers
5. The dependent variables were approximately normally distributed for each category of
the independent variable
6. Homogeneity of variance was present
Assumptions one, two, and three were self-evident from the data set as displayed in tables nine
and 10. Histograms were generated to assess normality. Scatterplots were generated to assess
linearity, homogeneity of variance, and outliers. Chapter five includes a discussion of the results
of assumption testing and displays figures of the histograms, scatterplots, and SPSS output
generated in this process.
Assumptions & Limitations
The principal assumption in this study is that the WAVi MedicalTM system provides valid
and reliable assessment of P300 waveforms in response to an oddball paradigm as the device was
not independently validated by the research team. This assumption is reasonable given: 1)
previously reported utility of P300 evoked potentials as a neurocognitive assessment metric (Sur
& Sinha, 2009; Parra et al., 2012; Yener, 2013, van Dinteren 2014; Grover et al., 2017; Clayton
et al. 2020), 2) reported success using the WAVi MedicalTM system for conducting P300 evoked
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potential neurocognitive assessments in at least two recent publications (Grover et al., 2017;
Clayton et al., 2020), and 3) similar ongoing neurocognition clinical studies are employing the
WAVi MedicalTM system (National Institutes of Health, 2018; Clinicaltrials.gov, 2018). Mulkey
et al. (2019) accepted comparable assumptions as the first investigators to evaluate the potential
utility of the Ceribell device (Ceribell, Inc., 2018), an FDA-cleared limited lead EEG device, for
delirium identification and assessment among ICU patients.
One limitation of a retrospective secondary data study is that causality cannot be
determined (Polit and Beck, 2017). As a proof-of-concept study, this study primarily sought to
identify associations that may be useful in generating hypotheses to guide future research.
Another potential limitation of a study that uses secondary data is that data could be inaccurate or
incomplete (Hulley et al., 2013). Additionally, data may have been collected from an unideal
population (e.g., unequal proportions of gender, age, or ethnicity) and important covariates may
not have been identified and recorded (Hulley et al., 2013). A third potential limitation of this
study is the relatively higher likelihood of a Type II error (i.e., failing to reject a false null
hypothesis) given the relatively small postoperative assessment sample size available from the
data source study. A more detailed discussion of limitations is presented in chapter six.
Chapter Summary
This study was important because the WAVi MedicalTM system may one day enable
anesthesia providers to: 1) rapidly perform a valid and reliable neurocognitive assessment that is
more detailed, sensitive, and specific than questionnaire-based neurocognitive screening tools, 2)
predict POD risk and stratify patients into risk categories, 3) detect mild cognitive impairments
currently missed by brief cognitive screening tools (e.g., Mini-Cog©), and 4) objectively track
the progression of postoperative cognitive changes over time. Specifically, this study
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investigated the potential clinical utility of P300 AEP (i.e., amplitude and latency) obtainable
with a POC EEG brain health assessment device. This contribution was significant because,
pending further investigation, a device capable of rapidly and reliably predicting, identifying,
and tracking perioperative neurocognitive disorders may enhance anesthesia providers’ ability to
develop and evaluate the effectiveness of perioperative brain health protection protocols and
clinical pathways in an effort to reduce the incidence and severity of POD in older surgical
patients (Axley & Schenning, 2015).
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Chapter 5: Results
Chapter Overview
The purpose of this study was to explore baseline and postoperative neurocognitive
characteristics that may help to establish novel predictive and trend metrics for perioperative
neurocognitive assessment in older surgical patients. In this study, relationships between P300
AEPs and MoCA scores were explored, and differences in pre- to postoperative P300 AEP
change scores between participants who received two or more potentially neuroprotective
multimodal anesthetic adjunct medications versus those who did not were evaluated. This study
was important because neurobiomarkers obtainable with the POC EEG brain health assessment
device, WAVi MedicalTM (Boulder, CO), might one day provide anesthesia providers with a
more detailed perioperative assessment of a patient’s brain, the primary target of anesthesia, than
is currently available with questionnaire-based assessment tools (e.g., MoCA, Mini-Cog©, and
CAM).
A non-experimental ex post facto secondary data analysis design was used to
retrospectively: 1) compare participants’ baseline P300 AEPs to MoCA scores before surgery
and anesthesia and 2) evaluate for group differences in pre- to postoperative P300 AEP change
scores between participants who received two or more potentially neuroprotective multimodal
anesthetic adjunct medications versus those who did not.
Chapter five offers a succinct presentation of the study’s results. Results are presented in
a narrative format supplemented with figures and tables. The chapter begins with a description of
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the variables and data cleaning process and is followed by a summary of the statistical findings
for each of the two study aims.
Review of Data Acquisition
Following IRB approval from VCU, data records meeting this study’s criteria were
extracted from the VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID
22988. As previously mentioned, data in this database was collected using a longitudinal,
repeated measures design to conduct a prospective observational trial with a set of pretests and
multi-observation post-tests. At the time of data extraction for the current study, the database
contained 20 participant records. After the evaluation of each record for sufficient data to meet
this study’s inclusion and exclusion criteria, the final sample size was n = 15 for the first study
aim and n = 10 for the second study aim. Figure 23 illustrates the study’s exclusion criteria for
both study aims.
Figure 23
Study Exclusion Flow Chart
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Data Preparation and Cleaning
Data was inspected for accuracy and missing values. No missing values were identified.
Data was coded using SPSS and assigned as either scale (i.e., continuous) or nominal (i.e.,
categorical) in SPSS for the purpose of analysis. Table 10 lists the study variables and their
respective coding.
Table 10
Study Variables and Coding
Variable

Coding

Category

Age
Sex

Age in years
1 = “Male”
2 = “Female”
1 = “African American”
2 = “Caucasian”
3 = “Hispanic or Latino”a
4 = “Asian”a
5 = “2 or more races”a
6 = “Self-identify”a
1 = “ASA I - A normal healthy patient”
2 = “ASA II - A patient with mild
systemic disease”
3 = “ASA III - A patient with severe
systemic disease”
4 = “ASA IV - A patient with severe
systemic disease that is a constant threat
to life”
5 = “ASA V - A moribund patient who
is not expected to survive without the
operation”a
6 = “ASA VI - A declared brain-dead
patient whose organs are being removed
for donor purposes”a
Score 0-30
Amplitude in microvolts

Scale / Continuous
Nominal / Categorical

Latency in milliseconds
1 = “Sevoflurane”
2 = “Isoflurane”a
3 = “Desflurane”a

Scale / Continuous
Nominal / Categorical

Ethnicity

ASA Score

MoCA Score
P300
Amplitude
P300 Latency
Primary
Anesthetic
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Nominal / Categorical

Nominal / Categorical

Scale / Continuous
Scale / Continuous

Table 10 Continued
Primary
Anesthetic
Length of
Anesthesia
Surgical
Procedure

4 = “Propofol”
5 = “Other”a
Time in minutes

Nominal / Categorical

0 = “Spine”
1 = “Shoulder Arthroplasty”
2 = “Major Invasive Urology”
3 = “Laparoscopic Intraabdominal”
Time in minutes

Nominal / Categorical

Scale / Continuous

Length of
Surgery
PNMMA
0 = “No”
Received (≥2)
1 = “Yes”
P300
Pre- to postoperative amplitude change
Amplitude
in microvolts
Change Score
P300
Pre- to postoperative latency change in
Amplitude
milliseconds
Change Score
a
No study participants were in this category

Scale / Continuous
Nominal / Categorical
Scale / Continuous

Scale / Continuous

Descriptive Statistical Analysis
Descriptive analysis was completed using REDCap®’s imbedded statistical software. The
following descriptive statistics are presented in a narrative format supplemented with figures and
tables: 1) sample size, 2) age (range and mean), 3) sex (% female vs male), 4) ethnicity (%
African American and Caucasian), 5) American Society of Anesthesiology Classification Score,
6) surgical procedure (nominal), 7) length of surgery (range and mean), 8) type of anesthetic
(nominal), 9) duration of anesthetic, and 10) the administration of PNMMA agents (categorical).
For the first study aim, evaluate the ability of participants’ preoperative baseline P300
latency and P300 amplitude to predict participants’ cognitive function, the final sample size was
15. Participants’ age ranged from 61-82. The mean age was 72. Four participants identified as
female (27%), and 11 participants identified as male (73%). Four participants identified as
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African American (27%), and 11 participants identified as Caucasian (73%). Table 11
summarizes the descriptive statistics for the study aim one.
Table 11
Descriptive Statistics – Aim 1
Variable

Sample Size
Age
Sex
Female
Male
Ethnicity
African American
Caucasian
ASA Score
II
III
IV

Continuous: Mean (Min,
Max)
Categorical: n (%)
n = 15
72 (61, 82)
4 (27)
11 (73)
4 (27)
11 (73)
3 (20)
10 (67)
2 (13)

For study aim two, evaluate for group differences in pre- to postoperative P300 AEP
change scores between participants who received two or more potentially neuroprotective
multimodal anesthetic adjunct medications versus those who did not, the final sample size was
10. The sample size of group one (i.e., participants who did receive two or more PNMMA
medications) was six. Group one participants’ age ranged from 66-79. The mean age was 73.2.
Three participants identified as female (50%), and three participants identified as male (50%).
Two participants identified as African American (33%), and four participants identified as
Caucasian (67%). Two participants’ (33%) ASA was II, three participants’ (50%) ASA was III,
and one participant’s (17%) ASA was IV. All participants in group one received a sevofluranebased anesthetic. Group one’s duration of anesthesia ranged from 200-495 minutes. The mean
duration of anesthesia for group one was 299 minutes. Two participants (33%) underwent
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laparoscopic intra-abdominal surgery. Three participants (50%) underwent major invasive
urologic surgery. One participant (17%) underwent shoulder arthroplasty. Group one
participants’ length of surgery ranged from 150-428 minutes. The mean duration of surgery for
group one was 253 minutes.
The sample size of group two (i.e., participants who did not receive two or more
PNMMA medications) was four. Group two participants’ age ranged from 72-82. The mean age
was 76.5. One participant identified as female (25%), and three participants identified as male
(75%). All four participants identified as Caucasian (100%). One participant’s (25%) ASA was
II and three participants’ (75%) ASA was III. One participant (25%) in group two received a
propofol-based anesthetic, and three participants (75%) in group two received a sevofluranebased anesthetic. Group two’s duration of anesthesia ranged from 97-293 minutes. The mean
duration of anesthesia for group two was 218 minutes. Two participants (50%) underwent major
orthopedic spine surgery. Two participants (50%) underwent shoulder arthroplasty. Group two
participants’ length of surgery ranged from 69-214 minutes. The mean duration of surgery for
group two was 167 minutes. Table 12 summarizes the descriptive statistics for the second study
aim.
As previously noted, the target population for this study was surgical patients over the
age of 60 years presenting for elective, non-cardiac surgery and anesthesia. The accessible
population was a convenience sample of surgical patients over the age of 60 years presenting to
the VCU/VCUHS PACE clinic for preoperative evaluation and subsequently for surgery and
anesthesia who underwent perioperative neurocognitive assessment while enrolled in the study
“Perioperative Brain Health” – IRB HM20019839. This setting increased the likelihood that
study results would be generalizable to a wide variety of surgical procedures and across a large
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Table 12
Descriptive Statistics – Aim 2
Variable

Sample Size
Age
Sex
Female
Male
Ethnicity
African American
Caucasian
ASA Score
II
III
IV
Primary Anesthetic
Propofol
Sevoflurane
Length of Anesthesia
(Minutes)
Surgical Procedure
Laparoscopic
Intraabdominal
Major Invasive Urology
Spine
Shoulder Arthroplasty
Length of Surgery
(Minutes)

Group 1

Group 2

PNMMA – Yes

PNMMA – No

Continuous: Mean (Min, Max)
Categorical: n (%)
n=6
73.2 (66, 79)

Continuous: Mean (Min, Max)
Categorical: n (%)
n= 4
76.5 (72, 82)

3 (50)
3 (50)

1 (25)
3 (75)

2 (33)
4 (67)

0
4 (100)

2 (33)
3 (50)
1 (17)

1 (25)
3 (75)
0

0
6 (100)

1 (25)
3 (75)

299 (200, 495)

218 (97, 293)

2 (33)
3 (50)
1 (17)
0

0
0
2 (50)
2 (50)

253 (159, 428)

167 (69, 214)

spectrum of patient conditions and comorbidities. Given the sample size for this study, a true
representation of the diversity of the general population of older surgical patients is not
realistically feasible. However, the sample population is reasonably diverse including
participants from male and female gender, two ethnic groups, and ages ranging from 66-82.
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Assumption Testing
Prior to performing multivariate statistical analysis, each variable was evaluated for the
following assumptions:
Regression:
1. The dependent variable was interval or ratio level data
2. There were two or more independent variables with continuous data
3. Independence of observations was present
4. Normality was present
5. There was a linear relationship between the two variables
6. Homoscedasticity was present
7. Multicollinearity was absent
8. There were no significant outliers
Assumptions one, two, and three are self-evident from the data set as previously displayed in
tables nine and ten. Histograms were generated to assess for normality (i.e., a normal distribution
of the variables in a data set), skewness (i.e., symmetry of a data set’s distribution), and kurtosis
(i.e., peakedness of a data set’s distribution) (Tabachnick and Fidell, 2013).
Skewness and kurtosis can be assessed both graphically (e.g., histogram with a curve
overlay) and statistically. A graphed data set that is positively skewed has an increased number
of data points on the left side of the histogram and a long right-sided tail on the curve overlay. A
graphed data set that is negatively skewed has an increased number of data points on the right
side of the histogram and a long left-sided tail on the curve overlay. Positive kurtosis refers to a
tall, peaked distribution with short, thick tails on a histogram relative to a normal distribution,
and negative kurtosis refers to a flattened distribution (Tabachnick and Fidell, 2013). Skewness
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and kurtosis statistics can be converted to z-scores by dividing the statistic by its standard error
with the acceptable range being a z-score of negative three to positive three (Tabachnick and
Fidell, 2013).
Scatterplots were generated to assess for linearity (i.e., a straight-line forming association
between two variables), homoscedasticity (i.e., one variable’s variance is identical across all
values for another variable), and outliers (i.e., data points that significantly differ from the
majority of other data points within a data set) (Tabachnick and Fidell, 2013). A Pearson
correlation matrix of the independent variables was created to assess for multicollinearity (i.e.,
correlated independent variables) (Tabachnick and Fidell, 2013). A Pearson correlation of less
than 0.8 is indicative of an acceptable absence of multicollinearity among variables (Tabachnick
and Fidell, 2013).
For aim one, the DV was MoCA score and the IVs were P300 amplitude and latency. The
distribution of the DV (i.e., MoCA Score) exhibited a negative skewness (i.e., skewed left) of 1.31 (standard error 0.58) and positive kurtosis of 1.05 (standard error 1.12). The distribution of
the IV amplitude exhibited a slight positive skewness (i.e. skewed right) of 0.55 (standard error
0.58) and slight positive kurtosis of 0.32 (standard error 1.12). The distribution of the IV latency
exhibited a slight positive skewness (i.e., skewed right) of 0.15 (standard error 0.58) and slight
positive kurtosis of 0.36 (standard error 1.12). Figures 24, 25, and 26 display the histograms with
a curve overlay generated in SPSS for aim one. Figure 27 displays the results of statistical
analysis for skewness and kurtosis of the aim one variables.
The MoCA-amplitude scatterplot exhibited a weak negative relationship. Homogeneity of
variance was present and appeared relatively consistent, and no extreme outliers were noted.
Figure 28 displays the MoCA-amplitude scatterplot. The MoCA-latency scatterplot exhibited a
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Figure 24
Histogram of the Distribution of the Aim One DV, MoCA Score

weak positive relationship. Homogeneity of variance was present and appeared relatively
consistent on the MoCA-latency scatterplot. No extreme outliers were noted.
Figure 25
Histogram of the Distribution of the Aim One IV, Amplitude

101

Figure 26
Histogram of the Distribution of the Aim One IV, Latency

Figure 27
SPSS Output: Skewness and Kurtosis of the Aim One Variables

Figure 29 displays the MoCA-latency scatterplot. A Pearson correlation matrix was
generated to assess for multicollinearity between the two independent variables (i.e., amplitude
and latency). The Pearson correlation was calculated to be r = -0.111, n = 15, and the
relationship was not significant p = 0.695. Multicollinearity was not present. Figure 30 displays
the SPSS output for the correlation matrix.
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Figure 28
Scatterplot of the Distribution of the Aim One IV, Amplitude and DV, MoCA Score

Figure 29
Scatterplot of the Distribution of the Aim One IV, Latency and DV, MoCA Score
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Figure 30
SPSS Output: Collinearity Statistics of the Aim One Variables

ANOVA:
1. The dependent variable was interval or ratio level data
2. The independent variable consisted of two or more independent, categorical groups
3. There was independence of observations
4. There were no significant outliers
5. The dependent variables were approximately normally distributed for each category of
the independent variable
6. Homogeneity of variance was present
Assumptions one, two, and three for aim two were also self-evident from the data set previously
displayed in tables nine and 10. Histograms were generated to assess for normality (i.e., a normal
distribution of the variables in a data set), skewness (i.e., symmetry of a data set’s distribution),
and kurtosis (i.e., peakedness of a data set’s distribution) (Tabachnick and Fidell, 2013).
As previously noted for aim one, skewness and kurtosis may be assessed graphically
(e.g., histogram with a curve overlay), statistically, or by a combination of the two. A positively
skewed data set presents as an increased number of data points on the left side of the histogram
and a long right-sided tail on the curve overlay. A negatively skewed data set presents as an
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increased number of data points on the right side of the histogram and a long left-sided tail on the
curve overlay. Positive kurtosis presents as a tall, peaked distribution with short, thick tails on a
histogram, whereas negative kurtosis presents as a flattened curve relative to a normal
distribution (Tabachnick and Fidell, 2013). The calculated statistics for skewness and kurtosis
can be converted to z-scores be dividing the statistic by its standard error. The generally
acceptable range for these values is a z-score between negative and positive three (Tabachnick
and Fidell, 2013).
Scatterplots were generated to assess for linearity (i.e., a straight-line forming association
between two variables), homoscedasticity (i.e., one variable’s variance is identical across all
values for another variable), and outliers (i.e., data points that significantly differ from the
majority of other data points within a data set) (Tabachnick and Fidell, 2013). For aim two, the
DVs were P300 amplitude and latency change scores and the IV was whether or not (i.e., Yes /
No) participants received two or more PNMMA adjunct medications.
The distribution of the DV P300 amplitude change score exhibited a slight positive
skewness (i.e., skewed right) of 0.15 (standard error 0.69) and negative kurtosis of -2.189
(standard error 1.33). The distribution of the DV P300 latency change score exhibited a slight
positive skewness (i.e., skewed right) of 0.05 (standard error 0.69) and slight negative kurtosis of
-0.55 (standard error 1.33). The distribution of the IV PNMMA (Yes / No) exhibited a slight
negative skewness (i.e. skewed left) of -0.48 (standard error 0.69) and negative kurtosis of -2.28
(standard error 1.34). Figures 31, 32, and 33 display the histograms with a normal curve overlay
generated for aim two. Figure 34 displays the results of statistical analysis for skewness and
kurtosis of the aim two variables.
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Figure 31
Histogram of the Distribution of the Aim Two DV, Amplitude Change Score

Figure 32
Histogram of the Distribution of the Aim Two DV, Latency Change Score
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Figure 33
Histogram of the Distribution of the Aim Two IV, PNMMA (Yes / No)

Figure 34
SPSS Output: Skewness and Kurtosis of the Aim Two Variables

The PNMMA-amplitude boxplot displayed in Figure 35 exhibited a positive association
between receiving PNMMA (Yes / No) and amplitude change scores. The PNMMA-latency
boxplot displayed in Figure 36 exhibited little to no association between receiving PNMMA
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Figure 35
Boxplot of the Aim Two DV, Amplitude Change Score and IV, PNMMA (Yes / No)

Figure 36
Boxplot of the Aim Two DV, Latency Change Score and IV, PNMMA (Yes / No)

(Yes / No) and latency change scores. Homogeneity of variance was present and appeared
relatively consistent, and no extreme outliers were noted for these boxplots.
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Statistical Analysis
The first study aim was to evaluate the ability of participants’ preoperative baseline P300
latency (i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’
cognitive function. This study used regression to understand whether auditory P300 amplitude
(in microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among
older surgical patients as assessed by MoCA. Each variable was considered independently as
they measure two separate constructs of neurocognition, namely cognitive resources (i.e., brain
power) and cognitive efficiency (i.e., brain speed).
Hypothesis one (H1) assessed for a relationship between participants P300 amplitude and
MoCA scores.
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.
H1 was tested using linear regression. A simple linear regression was calculated to predict
participants’ MoCA scores based on their P300 amplitude. The regression equation was not
significant (F(1,13) = 0.021, p > 0.05) with an r2 of 0.002. In this sample, P300 amplitude was
not a significant predictor of MoCA score. Figures 37 and 38 show the model summary and
coefficients for the analysis of H1 respectively.
Figure 37
SPSS Output: Model Summary for Analysis of H1
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Figure 38
SPSS Output: Coefficients for Analysis of H1

Hypothesis two (H2) assessed for a relationship between participants P300 latency and
MoCA scores.
Hypothesis #2: Increased P300 latency will be predictive of lower MoCA scores.
H2 was tested using linear regression. A simple linear regression was calculated to predict
participants’ MoCA scores based on their P300 latency. The regression equation was not
significant (F(1,13) = 0.052, p > 0.05) with an r2 of 0.004. In this sample, P300 latency was not a
significant predictor of MoCA score. Figures 39 and 40 show the model summary and
coefficients for the analysis of H2 respectively.
Figure 39
SPSS Output: Model Summary for Analysis of H2
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Figure 40
SPSS Output: Coefficients for Analysis of H2

The second study aim was to evaluate for group differences in pre- to postoperative P300
AEP change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between
participants who received two or more PNMMA medications (i.e., magnesium, lidocaine, and/or
ketamine) versus those who did not.
Hypothesis three (H3) assessed for a difference in P300 amplitude between participants
who received two or more PNMMA medications versus those who did not.
Hypothesis #3: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a larger positive change in their P300
amplitude, measured as a pre- to postoperative change score in microvolts.
A one-way ANOVA was computed to determine if participants who received two or more
PNMMA agents demonstrated a larger positive change in their P300 amplitude than participants
who did not receive these medications intraoperatively.
As seen in Figure 41, participants who did not receive two or more PNMMA medications
had a mean reduction in their P300 amplitude (-3.5). However, participants who did receive two
or more PNMMA medications had a mean increase in their P300 amplitude (4.3). These findings
supported study aim two, hypothesis three.
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Figure 41
SPSS Output: Descriptives for Analysis of H3

As seen in Figure 42, in this sample, a significant difference was identified between the two
groups (F(1,8) = 12.093, p < 0.05).
Figure 42
SPSS Output: ANOVA for Analysis of H3

Post hoc analysis revealed that participants who received two or more PNMMA medications
demonstrated a larger positive postoperative change in their P300 amplitude (M = 4.33, sd =
4.29, 95% CI = [-0.17, 8.83]) than participants who did not (M = -3.45, sd = 1.19, 95% CI = [5.34, -1.56]).
Hypothesis four (H4) assessed for a difference in P300 latency between participants who
received two or more PNMMA medications versus those who did not.
Hypothesis #4: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in their
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P300 latency relative to their baseline, measured as a pre- to postoperative change score
in milliseconds.
A one-way ANOVA was computed to determine if participants who received two or more
PNMMA agents demonstrated a smaller degree of prolongation in their P300 latency than
participants who did not receive these medications intraoperatively. No significant difference
was identified (F(1, 8) = 0.245, p > 0.05). Participants’ P300 latency change scores did not differ
significantly between the two groups. Participants who received two or more PNMMA agents
had a mean change score of 14.76 milliseconds (sd = 76.01, 95% CI = [-65.10, 94.43]).
Participants who did not receive two or more PNMMA agents had a mean change score of -9
milliseconds (sd = 70.53, 95% CI = [-121.23, 103.23]). Figures 43 and 44 show the descriptives
and ANOVA for the analysis of H4.
Figure 43
SPSS Output: Descriptives for Analysis of H4

Post Hoc Power Analysis
Post hoc power analysis was performed using the Daniel Soper Statistical Power Calculator
version 4.0 (Soper, 2021). In the post hoc power analysis, the power of the first study aim was
calculated to be very low at 0.05 for each predictor (n = 15, 2 predictors (considered
independently as they measure two separate constructs of neurocognition) calculated effect size
of 0.002 (amplitude) and 0.004 (latency), and α of 0.05). This result was lower than anticipated
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based on the a priori power analysis and indicates a 5% chance of detecting an effect if one
exists and a 95% chance of a Type II error, a false acceptance of the null hypothesis.
Figure 44
SPSS Output: ANOVA for Analysis of H4

For second study aim, hypothesis three, the post hoc power was calculated to be acceptable at
0.94 (n = 10, 1 response, calculated effect size of 0.6, and α of 0.05). This result was slightly
higher than anticipated based on the a priori power analysis and indicates an 94% chance of
detecting an effect if one exists and a 16% chance of a Type II error, false acceptance of the null
hypothesis. For second study aim, hypothesis four, the post hoc power was calculated to be very
low at 0.08 (n = 10, 1 response, calculated effect size of 0.03, and α of 0.05). This result was
lower than anticipated based on the a priori power analysis and indicates an 8% chance of
detecting an effect if one exists and a 92% chance of a Type II error, false acceptance of the null
hypothesis.
Chapter Summary
Chapter five presented the results of this study’s statistical analyses to evaluate the ability
of participants’ preoperative baseline P300 latency and amplitude to predict participants’ MoCA
scores and assess for group differences in pre- to postoperative P300 AEP change scores between
participants who received two or more PNMMA medications versus those who did not. Linear
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regression was used to analyze the relationship between participants’ preoperative baseline P300
latency and amplitude and MoCA scores. No significant relationship was identified between
either P300 latency or amplitude and MoCA scores. ANOVA was used to evaluate for
differences in pre- to postoperative P300 AEP change scores between participants who received
two or more PNMMA medications and those who did not. A statistically significant
postoperative positive change in P300 amplitude was identified in participants who received two
or more PNMMA medications (e.g., lidocaine, ketamine, magnesium) versus those who did not.
No significant postoperative change in P300 latency was identified in participants who received
two or more PNMMA medications (e.g., lidocaine, ketamine, magnesium) versus those who did
not. Chapter six discusses potential clinical implications of these findings, study limitations, and
recommendations for future research.
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Chapter 6: Conclusions and Recommendations
Chapter Overview
Chapter six presents a study summary and the important conclusions drawn from the data
presented in chapter five. The potential clinical implications for anesthesia practice are
discussed. The chapter concludes with recommendations for future research.
The Problem
The perioperative brain health of older surgical patients is a public health and research
priority (American Society of Anesthesiologists, 2019). POD is a risk factor for long-term
neurocognitive decline, and the rate of decline is associated with POD severity (Vasunilashorn et
al., 2018). Baseline cognitive function is a strong, independent predictor for POD (Culley et al.,
2017). The International Perioperative Neurotoxicity Working Group recommends preoperative
baseline neurocognitive assessment for older surgical patients (Berger, et al., 2018). Cognitive
screening tools trialed in anesthesia are not routinely incorporated into clinical practice related to
validity, reliability, or practicality considerations (Berger, et al., 2018). The ideal perioperative
neurocognitive assessment would be rapid, easily-administrable, valid, reliable, automatically
scored, void of language, cultural, and education bias and cost-efficient (Axley & Schenning,
2015). No such assessment has been identified to date.
Anesthesia providers routinely assess multiple organ systems (e.g., cardiovascular—
auscultation of heart sounds, METs; respiratory—auscultation of lung sounds; laboratory
values—hemoglobin/hematocrit, glucose, electrolytes, hepatic enzymes). However, the brain,
anesthesia’s primary target, is rarely assessed beyond orientation to person, place, time and task.
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Crosby et al. (2011) lamented this problem:
…that we currently make no effort to identify [older patients with a vulnerable brain
state] preoperatively is an embarrassing state of affairs considering that… perioperative
cognitive morbidity in the elderly is so common and costly (p. 1267).
One major barrier to rigorous and routine perioperative neurocognitive evaluation is that no
easily-administrable, rapid, reliable, highly sensitive and specific assessment of an individual’s
cognitive resources and efficiency is currently available.
A POC EEG device capable of rapidly performing easily-administrable, reliable,
sensitive, and specific neurocognitive assessments at the bedside might enable anesthesia
providers to better assess baseline neurocognitive function in older surgical patients prior to
surgery and anesthesia. Objective assessments derived from a POC EEG-based neurocognitive
assessment device may detect neurocognitive baseline changes as well as postoperative changes
(e.g., mild or even subsyndromal cognitive impairments) that are currently missed in a subset of
patients by clinically utilized cognitive assessment tools (e.g., A&O x4).
Study Purpose, Research Questions, and Hypotheses
As a proof-of-concept study, this research primarily sought to explore associations and
generate hypotheses to guide future research. Specifically, the purpose of the study was to
explore potential neurobiomarkers derived from EEG-based P300 auditory evoked potentials
(AEPs) that may serve as both predictive and trend metrics of perioperative neurocognitive
function in older surgical patients. Such neurobiomarkers might facilitate a more rigorous
perioperative assessment of a patient’s brain state than do questionnaire-based assessment tools
(e.g., What is your name?, Where are you right now?, What is today’s date?, Do you know why
you are here?). In this study, relationships between P300 AEPs and MoCA scores were explored
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and differences in pre- to postoperative P300 AEP change scores between participants who
received two or more PNMMA adjunct medications versus those who did not were evaluated.
Pending further investigation, EEG-based neurobiomarkers may assist the development of
perioperative brain health protection protocols that reduce the incidence and/or severity of
perioperative neurocognitive disorders in older surgical patients.
Review of Theory
Donabedian’s Theoretical Model for Evaluating the Quality of Medical Care guided the
design and implementation of this study. Donabedian’s framework is the most commonly used
theoretical framework for evaluating the quality of healthcare services (Ayanian and Markel,
2016). According to Donabedian, three concepts (i.e., structure, process, and outcome) are the
guiding principles for quality improvement. Donabedian’s model was appropriate for this study
because the model is descriptive, explanatory, accurate, practical, simple, consistent, and acute in
identifying links between practice processes and patient outcomes in the perioperative setting
(Birkmeyer et al., 2004; Centurion et al., 2018; Hannan et al., 2001; Moore et al., 2015; Rose et
al., 2019; Tsai et al., 2013).
Review of the Methodology
The study employed a non-experimental ex post facto secondary data analysis design.
This design was used to retrospectively compare participants’ baseline P300 AEPs to MoCA
scores before surgery and anesthesia and to evaluate for group differences in pre- to
postoperative P300 AEP change scores between participants who received two or more PNMMA
medications versus those who did not. This study’s research question was: Could P300 AEPs
obtained using the WAVi MedicalTM system potentially enhance perioperative brain health
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assessment and provide neurobiomarkers that aid in the development of perioperative brain
health protection protocols for older surgical patients?
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300 latency
(i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’ cognitive
function. This study used regression to understand whether auditory P300 amplitude (in
microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among
older surgical patients as assessed by MoCA. Each variable was considered
independently as they measure two separate constructs of neurocognition, namely
cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between
participants who received two or more potentially neuroprotective multimodal anesthetic
adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did
not.
Hypothesis #3: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a larger positive change in their
P300 amplitude, measured as a pre- to postoperative change score in microvolts.
Hypothesis #4: Participants who received two or more potentially neuroprotective
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in
their P300 latency relative to their baseline, measured as a pre- to postoperative
change score in milliseconds.
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Regression was completed to evaluate data for study aim #1 to assess whether auditory
P300 amplitude (in microvolts) and auditory P300 latency (in milliseconds) predicted
participants’ MoCA scores. A pair of one-way ANOVA analyses were completed for study aim
#2 to determine whether a difference existed in pre-and postoperative P300 amplitude (in
microvolts) and P300 latency (in milliseconds) change scores between participants who received
two or more PNMMA medications and those who did not.
Synopsis of Major Findings
For study aim one, regression was employed to evaluate whether auditory P300
amplitude or latency were predictive of MoCA scores.
H1: Lower P300 amplitude will be predictive of lower MoCA scores.
The regression equation was not significant (F(1,13) = 0.021, p > 0.05) with an r2 of 0.002. P300
amplitude was not a significant predictor of MoCA score in this sample.
H2: Increased P300 latency will be predictive of lower MoCA scores.
The regression equation was not significant (F(1,13) = 0.052, p > 0.05) with an r2 of 0.004. P300
latency was not a significant predictor for MoCA score in this sample.
For study aim two, ANOVA was employed to evaluate for group differences in pre- to
postoperative P300 AEP change scores between participants who received two or more PNMMA
medications and participants who did not.
H3: Participants who received two or more potentially neuroprotective multimodal
anesthetic agents will demonstrate a larger positive change in their P300 amplitude,
measured as a pre- to postoperative change score in microvolts.
The analysis identified a significant difference between the two groups (F(1,8) = 12.093, p <
0.05). Post hoc analysis revealed that participants who received two or more PNMMA
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medications demonstrated a larger positive postoperative change in their P300 amplitude (M =
4.33, sd = 4.29, 95% CI = [-0.17, 8.83]) than participants who did not (M = -3.45, sd = 1.19, 95%
CI = [-5.34, -1.56]).
H4: Participants who received two or more potentially neuroprotective multimodal
anesthetic agents will demonstrate a smaller degree of prolongation in their P300 latency
relative to their baseline, measured as a pre- to postoperative change score in
milliseconds.
No significant difference was identified in participants’ P300 latency change scores between the
two groups (F(1, 8) = 0.245, p > 0.05). Participants who received two or more PNMMA agents
had a mean change score of 14.76 (sd = 76.01, 95% CI = [-65.10, 94.43]). Participants who did
not receive two or more PNMMA agents had a mean change score of -9 (sd = 70.53, 95% CI = 121.23, 103.23]).
Findings Related to the Literature
This study found no association between participants’ P300 AEPs and MoCA scores.
However, the sample population for this study consisted of four participants that identified as
African American (27%) and 11 that identified as Caucasian (73%). Rossetti et al. (2017)
identified that several components of the MoCA and previously established cut-off points for
cognitive impairment are not well suited for African Americans. In a sample of over 1,000
community-dwelling African Americans with an average age of 49 years and no subjective
cognitive complaints, the mean MoCA score was 22 (Rossetti et al., 2017). In this Rossetti et
al.’s study, 72% of participants were unable to complete the cube drawing task, 66% of
participants recalled fewer than 4/5 delayed free recall words, 63% were unable to complete the
sentence repetition task, and 45% failed the abstraction portion of the assessment (Rossetti et al.,
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2017). These factors all present challenges for the use of MoCA as a routine clinical preoperative
neurocognitive screening tool as MoCA may underestimate neurocognitive function in African
American patients (i.e., MoCA scores may be lower for African Americans than for Caucasians
with an equivalent level of cognitive function). Future research may consider evaluating the
relationship between P300 AEPs and MoCA scores while controlling for the impact of potential
ethnic and/or education biases on MoCA scores. It is also possible that MoCA provides different
information regarding a patient’s baseline neurocognitive state and ultimate risk for
postoperative neurocognitive changes (e.g., POD) than do P300 AEPs.
This study also evaluated group differences in pre- to postoperative P300 AEP change
scores between participants who received two or more PNMMA medications and participants
who did not. Lidocaine, ketamine, and magnesium are each reported to potentially reduce the
risk of postoperative cognitive impairment (Bhudia et al., 2007; Mack et al., 2009; Chen et al.,
2015; and Hovaguimian et al., 2018). Of particular interest, is the possible synergistic effect of
these potentially neuroprotective anesthetic adjunct medications. Mendonca et al. (2020)
reported a positive synergistic effect using a combination of lidocaine and magnesium for
perioperative pain management. Fang et al. (2020) reported that combining lidocaine with
ketamine “may be beneficial in shortening the onset of anesthesia, promoting postoperative
awaking…and [reducing the] incidence of adverse reactions” compared to administering
ketamine alone (p. 1). It is possible that similar synergistic neuroprotective effects exist when
combining two or more PNMMA for older surgical patients.
While the hypothesized differences in amplitude were supported (H3), the differences in
latency (H4) were not. This finding eludes to, but does not confirm, the possibility that a
synergistic neuroprotective effect could exist in older surgical patients receiving these
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medications. Of interest, the impact of sub-anesthetic doses of ketamine administered as a sole
agent have been previously determined to reduce auditory evoked P300 amplitude without an
impact on latency (Schwertner, et al., 2018). However, no studies that evaluated the impact of
ketamine, lidocaine, and/or magnesium on pre- to postoperative P300 AEP change scores in the
perioperative setting were identified in the literature. Future studies with larger sample sizes,
higher statistical power, and the inclusion of covariate analysis are needed to investigate the
potential neuroprotective effects of these medications and the potential utility of P300 AEPs as
perioperative neurophysiologic biomarkers for trending cognitive function in the clinical setting.
Limitations
This study has limitations related to design, variable measures, and statistical analysis.
These limitations may impact study findings and pose threats to the validity of study results.
Study limitations are presented and discussed in this section.
Selection bias poses a threat to the internal validity of this study. Selection bias results
from preexisting between-group differences when study participants are not randomized into
groups (Polit and Beck, 2017). Preexisting group differences (i.e., potential covariate factors),
other than the independent variable(s) may have confounding influence on the dependent
variable(s) (Polit and Beck, 2017). In the absence of covariate analysis, internal validity is
threatened (Polit and Beck, 2017).
For study aim 2, participants were assigned to one of two groups based on whether or not
the participants received PNMMA medications as displayed by Table 12 in chapter five. One
notable difference between these two groups was gender. In group one, 50% were male and 50%
were female. In group two, 75% were male, and 25% were female. Based on the limited number
of studies available, P300 amplitude may be impacted by gender (Melynyte et al., 2018). In a
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recent systematic review, 50% of the studies reviewed by the authors demonstrated a higher
amplitude on average for females versus males, purportedly resulting from anatomical and
hormonal differences (Melynyte et al., 2018). The authors recommend that gender be considered
as a potential covariate and note that additional studies and meta-analysis are needed to better
determine the strength of association between P300 AEPs and gender (Melynyte et al., 2018).
If a significant gender-associated difference does exist and is not controlled for as a
covariate in future studies, an identified between-groups difference in those who receive an
intervention (e.g., neuroprotective medication) and those who do not could be misinterpreted.
Due to the small, fixed sample size available for this retrospective exploratory secondary data
analysis, covariates were not incorporated into the analysis. Additional covariates that may be
considered in future studies include: age, length of anesthesia, pain, and the participants’
emotional state at the time of assessment. Future studies with larger sample sizes will benefit
from evaluating covariates to improve internal validity.
Instrumentation effect poses a threat to the internal validity of this study. Instrumentation
effect refers to a change in the assessment tool or methodology between two data collection
points (Polit and Beck, 2017). Even if the same instrument is used for repeated assessments,
instrumentation effect can bias study results if an assessment tool were more/less accurate on a
follow-up assessment relative to the initial assessment (Polit and Beck, 2017). As previously
mentioned, the principal assumption for this study was that the WAVi MedicalTM system
provides valid and reliable assessment of P300 AEPs as the device was not independently
validated by the data source study’s research team. This assumption was considered reasonable
given the reported: 1) utility of P300 AEPs as a neurocognitive assessment metric (Sur & Sinha,
2009; Parra et al., 2012; Yener, 2013, van Dinteren 2014; Grover et al., 2017; Clayton et al.
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2020), 2) success using the WAVi MedicalTM system for conducting P300 AEPs in at least two
recent publications (Grover et al., 2017; Clayton et al., 2020), and 3) ongoing neurocognition
clinical studies employing the WAVi MedicalTM system (National Institutes of Health, 2018;
Clinicaltrials.gov, 2018). However, without independent validation of the instrument or
documented validation studies in the literature, one cannot be absolutely certain of a device’s
test-retest reliability. Prior to future studies, independent validation of the test-retest reliability of
the WAVi MedicalTM system would reduce the potential for instrumentation effect and
strengthen the internal validity of future studies utilizing this device.
Low statistical power poses a threat to the statistical conclusion validity of this study. At
best, regression-based analyses are used to identify relationships between variables (Tabachnick
and Fidell, 2013). As previously noted, no relationship was identified between preoperative P300
amplitude and MoCA scores (H1) nor between preoperative P300 latency and MoCA scores (H2).
Hypothesized differences in pre- to postoperative amplitude change scores were supported (H3),
but the hypothesized differences in pre- to postoperative latency change scores (H4) were not.
However, the statistical conclusion validity of these results is threatened by a lack of statistical
power given the data source study’s relatively small sample size. Future studies will benefit from
an increase in sample size to increase statistical power and reduce the threat to statistical
conclusion validity.
Novelty effect poses a threat to the construct validity of this study. Novelty effect
references the potential impact that a study participant’s skepticism or enthusiasm about
participating in a new assessment technique can have on the results of initial assessment relative
to follow-up assessment (Polit and Beck, 2017). For example, during the data source study, a
participant may have been either more skeptical or enthusiastic when participating in
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preoperative neurocognitive assessments than they were when participating in postoperative
assessments as a result of novelty effect. Future studies may consider familiarizing study
participants with the study’s planned neurocognitive assessment techniques prior to the baseline
preoperative assessment in order to mitigate potential influence of novelty effects on study
outcomes to enhance conclusion validity.
The study’s sample poses a threat the external validity of this study. External validity
refers to the generalizability of the sample population’s results to the target population (Polit and
Beck, 2017). As previously mentioned, the data source study’s sample population was a
convenience sample of older surgical patients presenting to the PACE clinic at a single academic
medical center. The sample is reasonably diverse given the relatively small number of
participants available from the data source study including: male and female gender, two ethnic
groups, ages ranging from 66-82, and four different surgical services. However, this sample is
not ideally representative of the diversity among the target population (i.e., older surgical
patients throughout the U.S.). Future studies could consider utilizing a combination of quota
sampling and stratified randomization to obtain a sample population that better represents the
target population to enhance external validity (i.e., generalizability of the study’s results).
Conclusions and Recommendations for Future Research
This study evaluated potential relationships between P300 AEPs and MoCA scores and
differences in pre- to postoperative P300 AEP change scores between participants who received
two or more PNMMA adjunct medications versus those who did not. The ultimate goal of this
study was to contribute to the state of the science in search of a perioperative neurocognitive
assessment that is rapid, easily-administrable, valid, reliable, automatically scored, void of
language, cultural, and education bias and cost-efficient (Axley & Schenning, 2015). Such an
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assessment is needed as the brain, anesthesia’s primary target, is limitedly assessed within the
perioperative setting, perioperative cognitive morbidity among older surgical patients is common
and costly, and perioperative brain health is a public health and research priority (American
Society of Anesthesiologists, 2019).
In this study’s sample, an association between participants’ P300 AEPs and MoCA
scores was not identified. However, Berger et al. (2018) reported that there is insufficient data to
report sensitivity and specificity for MoCA in the perioperative setting and that MoCA has an
inherent education bias. Rossetti et al. (2017) identified that several components of the MoCA
and previously established cut-off points for cognitive impairment are not well suited for African
Americans. P300 AEP derived neurobiomarkers may also assess a different aspect of brain
health and provide alternative information related to a patient’s preoperative risk of POD versus
the MoCA assessment.
A statistically significant difference in P300 amplitude change scores between
participants who received two or more PNMMA medications versus those who did not was
identified. Participants who received two or more PNMMA medications demonstrated a larger
positive postoperative change in their P300 amplitude than participants who did not. This finding
may point to, but does not confirm, the possibility that a synergistic neuroprotective effect could
exist in older surgical patients receiving these medications. Future investigations with larger
samples sizes and higher statistical power are needed to further explore these effects.
This study found no significant difference in participants’ P300 latency change scores
between participants who received two or more PNMMA medications versus those who did not.
This finding may call attention to the potential for P300 signal amplitude to serve as a
perioperative neurophysiologic biomarker for trending cognitive function versus P300 latency.
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However, this finding may also be the result of an underpowered study. In future studies,
investigators may consider controlling for confounding perioperative factors that potentially
impact P300 auditory evoked potentials (e.g., gender, age, length of anesthesia, pain, and
emotional state at the time of assessment) as the clinical utility of these potential biomarkers is
refined.
Pending further investigation, EEG-based neurobiomarkers may assist the development
of perioperative brain health protection protocols that reduce the incidence and/or severity of
perioperative neurocognitive disorders in older surgical patients. First, future research may
consider evaluating the relationship between P300 AEPs and MoCA scores while controlling for
the impact of potential ethnic and/or education biases on MoCA scores. Second, investigators
may consider evaluating P300 amplitude as a perioperative neurocognitive trend metric while
controlling for potentially confounding perioperative factors. Future research may also consider
the potential utility of alternative EEG-based neurobiomarkers such as peak alpha frequencies or
theta/beta ratios. Future studies will benefit from an increase in sample size and resulting
increase in statistical power.
Investigation in search of a perioperative neurocognitive assessment that is rapid, easilyadministrable, valid, reliable, automatically scored, void of language, cultural, and education bias
and cost-efficient needs to be continued. The brain, anesthesia’s primary target, is currently
poorly assessed within the perioperative setting. Perioperative cognitive morbidity among older
surgical patients remains an all too common and costly phenomenon needing to be addressed.
Until a perioperative cognitive screening tool capable of 1) predicting POD risk and stratifying
patients into risk categories, 2) detecting mild cognitive impairments currently missed by brief
cognitive screening tools (e.g., MoCA, Mini-Cog©, and CAM), and 3) objectively tracking the
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progression of postoperative cognitive changes over time, reducing the incidence and severity of
POD will likely remain a problematic public health and research priority with few clearly
definitive perioperative brain health protection strategies for clinical application.
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